OA12727A - Indole-2-carboxamides as factor XA inhibitors. - Google Patents

Indole-2-carboxamides as factor XA inhibitors. Download PDF

Info

Publication number: OA12727A
Authority: OA; OAPI
Prior art keywords: chloro; indole; piperidin; thiophen; amide
Prior art date: 2001-11-22

Application number

OA1200400142A

Other languages

English (en)

Inventor

Marc Nazare

Melanie Essrich

David William Will

Hans Matt-Ter

Krut Ritter

Wolkmar Wehner

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-22

Filing date

2002-11-08

Publication date

2006-06-27

2002-11-08 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2006-06-27 Publication of OA12727A publication Critical patent/OA12727A/en

Links

VFHUJFBEFDVZPJ-UHFFFAOYSA-N 1h-indole-2-carboxamide Chemical class C1=CC=C2NC(C(=O)N)=CC2=C1 VFHUJFBEFDVZPJ-UHFFFAOYSA-N 0.000 title 1
229940123583 Factor Xa inhibitor Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 claims abstract description 302
238000000034 method Methods 0.000 claims abstract description 72
230000005764 inhibitory process Effects 0.000 claims abstract description 20
230000023555 blood coagulation Effects 0.000 claims abstract description 12
238000002560 therapeutic procedure Methods 0.000 claims abstract description 12
239000003814 drug Substances 0.000 claims abstract description 9
230000008569 process Effects 0.000 claims abstract description 6
208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 5
208000001435 Thromboembolism Diseases 0.000 claims abstract description 3
-1 phenylpyridyl Chemical group 0.000 claims description 262
239000002253 acid Substances 0.000 claims description 140
ZRQQXFMGYSOKDF-UHFFFAOYSA-N 1-propan-2-ylpiperidin-4-amine Chemical compound CC(C)N1CCC(N)CC1 ZRQQXFMGYSOKDF-UHFFFAOYSA-N 0.000 claims description 118
239000000203 mixture Substances 0.000 claims description 92
239000000460 chlorine Substances 0.000 claims description 70
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 69
125000000217 alkyl group Chemical group 0.000 claims description 69
125000001072 heteroaryl group Chemical group 0.000 claims description 62
229910052736 halogen Inorganic materials 0.000 claims description 55
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 54
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 49
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 45
150000002367 halogens Chemical class 0.000 claims description 45
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 42
RJCRRLMFYIXJAH-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 RJCRRLMFYIXJAH-UHFFFAOYSA-N 0.000 claims description 41
125000003118 aryl group Chemical group 0.000 claims description 41
229960000583 acetic acid Drugs 0.000 claims description 40
150000003839 salts Chemical class 0.000 claims description 38
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 36
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 36
229910052757 nitrogen Inorganic materials 0.000 claims description 36
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 31
230000015572 biosynthetic process Effects 0.000 claims description 30
150000002148 esters Chemical class 0.000 claims description 28
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 27
125000004122 cyclic group Chemical group 0.000 claims description 22
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 21
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 21
229910052760 oxygen Inorganic materials 0.000 claims description 21
239000001301 oxygen Substances 0.000 claims description 21
229910052717 sulfur Inorganic materials 0.000 claims description 21
239000011593 sulfur Substances 0.000 claims description 21
125000001041 indolyl group Chemical group 0.000 claims description 20
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 19
125000005842 heteroatom Chemical group 0.000 claims description 18
229920006395 saturated elastomer Polymers 0.000 claims description 18
125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 17
FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 17
125000002950 monocyclic group Chemical group 0.000 claims description 17
150000003536 tetrazoles Chemical class 0.000 claims description 17
125000002883 imidazolyl group Chemical group 0.000 claims description 16
BTDZSVPICJLNIN-UHFFFAOYSA-N 1-pyridin-4-ylpiperidin-4-amine Chemical compound C1CC(N)CCN1C1=CC=NC=C1 BTDZSVPICJLNIN-UHFFFAOYSA-N 0.000 claims description 15
125000002619 bicyclic group Chemical group 0.000 claims description 15
229910052801 chlorine Inorganic materials 0.000 claims description 15
CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 15
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 15
125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims description 14
KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims description 14
125000004433 nitrogen atom Chemical group N* 0.000 claims description 14
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 14
125000004076 pyridyl group Chemical group 0.000 claims description 14
125000001544 thienyl group Chemical group 0.000 claims description 14
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 14
150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 13
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims description 12
FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical compound C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 claims description 12
CIISBYKBBMFLEZ-UHFFFAOYSA-N 1,2-oxazolidine Chemical compound C1CNOC1 CIISBYKBBMFLEZ-UHFFFAOYSA-N 0.000 claims description 12
JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical compound C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 claims description 12
QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 claims description 12
POXWDTQUDZUOGP-UHFFFAOYSA-N 1h-1,4-diazepine Chemical compound N1C=CC=NC=C1 POXWDTQUDZUOGP-UHFFFAOYSA-N 0.000 claims description 12
MSRJJSCOWHWGGX-UHFFFAOYSA-N 2h-1,3-diazepine Chemical compound C1N=CC=CC=N1 MSRJJSCOWHWGGX-UHFFFAOYSA-N 0.000 claims description 12
WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 claims description 12
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 12
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 12
DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 claims description 12
XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 claims description 12
229910052794 bromium Inorganic materials 0.000 claims description 12
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 12
125000000524 functional group Chemical group 0.000 claims description 12
125000005843 halogen group Chemical group 0.000 claims description 12
ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 claims description 12
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 claims description 12
125000003373 pyrazinyl group Chemical group 0.000 claims description 12
125000003226 pyrazolyl group Chemical group 0.000 claims description 12
125000002098 pyridazinyl group Chemical group 0.000 claims description 12
125000000714 pyrimidinyl group Chemical group 0.000 claims description 12
HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 12
125000000335 thiazolyl group Chemical group 0.000 claims description 12
BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 12
LRANPJDWHYRCER-UHFFFAOYSA-N 1,2-diazepine Chemical compound N1C=CC=CC=N1 LRANPJDWHYRCER-UHFFFAOYSA-N 0.000 claims description 11
125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims description 11
125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 11
125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 claims description 11
125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 11
NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims description 11
YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 11
229910052731 fluorine Inorganic materials 0.000 claims description 11
125000000842 isoxazolyl group Chemical group 0.000 claims description 11
125000000168 pyrrolyl group Chemical group 0.000 claims description 11
125000001113 thiadiazolyl group Chemical group 0.000 claims description 11
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 10
125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 claims description 10
125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 claims description 10
125000004429 atom Chemical group 0.000 claims description 10
125000004432 carbon atom Chemical group C* 0.000 claims description 10
125000002541 furyl group Chemical group 0.000 claims description 10
239000001257 hydrogen Substances 0.000 claims description 10
229910052739 hydrogen Inorganic materials 0.000 claims description 10
125000001786 isothiazolyl group Chemical group 0.000 claims description 10
125000003831 tetrazolyl group Chemical group 0.000 claims description 10
NBNWLLXCAIOATK-UHFFFAOYSA-N 1-[(3-methoxyphenyl)methyl]indole-2-carboxylic acid Chemical compound COC1=CC=CC(CN2C3=CC=CC=C3C=C2C(O)=O)=C1 NBNWLLXCAIOATK-UHFFFAOYSA-N 0.000 claims description 9
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 9
125000002971 oxazolyl group Chemical group 0.000 claims description 9
VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 claims description 9
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 8
208000007536 Thrombosis Diseases 0.000 claims description 8
239000003146 anticoagulant agent Substances 0.000 claims description 8
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 8
229910052799 carbon Inorganic materials 0.000 claims description 8
SJGALSBBFTYSBA-UHFFFAOYSA-N oxaziridine Chemical compound C1NO1 SJGALSBBFTYSBA-UHFFFAOYSA-N 0.000 claims description 8
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims description 8
IBBLKSWSCDAPIF-UHFFFAOYSA-N thiopyran Chemical compound S1C=CC=C=C1 IBBLKSWSCDAPIF-UHFFFAOYSA-N 0.000 claims description 8
OEACEEHJARIXJW-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylic acid Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(O)=O)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 OEACEEHJARIXJW-UHFFFAOYSA-N 0.000 claims description 7
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims description 7
150000001408 amides Chemical class 0.000 claims description 7
125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 claims description 7
239000002243 precursor Substances 0.000 claims description 7
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 7
ZFCKJGACJXTSOI-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-7-methylindole-2-carboxylic acid Chemical compound C1=2C(C)=CC=CC=2C=C(C(O)=O)N1CC(=NO1)C=C1C1=CC=C(Cl)S1 ZFCKJGACJXTSOI-UHFFFAOYSA-N 0.000 claims description 6
208000005189 Embolism Diseases 0.000 claims description 6
230000001154 acute effect Effects 0.000 claims description 6
HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims description 6
201000010099 disease Diseases 0.000 claims description 6
125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims description 6
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 6
150000004702 methyl esters Chemical class 0.000 claims description 6
125000003386 piperidinyl group Chemical group 0.000 claims description 6
PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims description 6
125000005494 pyridonyl group Chemical group 0.000 claims description 6
125000000719 pyrrolidinyl group Chemical group 0.000 claims description 6
125000005493 quinolyl group Chemical group 0.000 claims description 6
238000001356 surgical procedure Methods 0.000 claims description 6
125000001425 triazolyl group Chemical group 0.000 claims description 6
DQJGJGNWFRPEHZ-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-4-carboxylic acid Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=C(C(O)=O)C=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 DQJGJGNWFRPEHZ-UHFFFAOYSA-N 0.000 claims description 5
ZUEKSECYPXHXAQ-UHFFFAOYSA-N 1-pyrimidin-4-ylpiperidin-4-amine Chemical compound C1CC(N)CCN1C1=CC=NC=N1 ZUEKSECYPXHXAQ-UHFFFAOYSA-N 0.000 claims description 5
DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims description 5
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 5
125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 5
125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 5
125000003384 isochromanyl group Chemical group C1(OCCC2=CC=CC=C12)* 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 5
125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 claims description 5
125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 5
208000037803 restenosis Diseases 0.000 claims description 5
230000002792 vascular Effects 0.000 claims description 5
IYCMYOWBZQNVBV-UHFFFAOYSA-N (1-propan-2-ylpiperidin-4-yl)methanamine Chemical compound CC(C)N1CCC(CN)CC1 IYCMYOWBZQNVBV-UHFFFAOYSA-N 0.000 claims description 4
CZSRXHJVZUBEGW-UHFFFAOYSA-N 1,2-thiazolidine Chemical compound C1CNSC1 CZSRXHJVZUBEGW-UHFFFAOYSA-N 0.000 claims description 4
125000005871 1,3-benzodioxolyl group Chemical group 0.000 claims description 4
ABADUMLIAZCWJD-UHFFFAOYSA-N 1,3-dioxole Chemical compound C1OC=CO1 ABADUMLIAZCWJD-UHFFFAOYSA-N 0.000 claims description 4
ZDEGYYDOWMXDCH-UHFFFAOYSA-N 1-[2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl]-5-methylsulfonyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(S(C)(=O)=O)=CC=C2N1CC(=O)NC1=CC=C(Cl)C=N1 ZDEGYYDOWMXDCH-UHFFFAOYSA-N 0.000 claims description 4
JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 claims description 4
MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 claims description 4
KGWNRZLPXLBMPS-UHFFFAOYSA-N 2h-1,3-oxazine Chemical compound C1OC=CC=N1 KGWNRZLPXLBMPS-UHFFFAOYSA-N 0.000 claims description 4
NTYABNDBNKVWOO-UHFFFAOYSA-N 2h-1,3-thiazine Chemical compound C1SC=CC=N1 NTYABNDBNKVWOO-UHFFFAOYSA-N 0.000 claims description 4
YHWMFDLNZGIJSD-UHFFFAOYSA-N 2h-1,4-oxazine Chemical compound C1OC=CN=C1 YHWMFDLNZGIJSD-UHFFFAOYSA-N 0.000 claims description 4
ZAISDHPZTZIFQF-UHFFFAOYSA-N 2h-1,4-thiazine Chemical compound C1SC=CN=C1 ZAISDHPZTZIFQF-UHFFFAOYSA-N 0.000 claims description 4
BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 claims description 4
XKTYXVDYIKIYJP-UHFFFAOYSA-N 3h-dioxole Chemical compound C1OOC=C1 XKTYXVDYIKIYJP-UHFFFAOYSA-N 0.000 claims description 4
GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical compound C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 claims description 4
NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 4
YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 claims description 4
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 4
125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 claims description 4
230000020764 fibrinolysis Effects 0.000 claims description 4
125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims description 4
125000005956 isoquinolyl group Chemical group 0.000 claims description 4
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 4
MIJCTFQIMWKOJZ-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[2-[4-(pyridin-4-ylamino)piperidine-1-carbonyl]indol-1-yl]acetamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)CN1C2=CC=CC=C2C=C1C(=O)N1CCC(NC=2C=CN=CC=2)CC1 MIJCTFQIMWKOJZ-UHFFFAOYSA-N 0.000 claims description 4
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims description 4
DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 4
229930192474 thiophene Natural products 0.000 claims description 4
230000002537 thrombolytic effect Effects 0.000 claims description 4
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 4
UOCPLRLVNRLSHU-UHFFFAOYSA-N (3-pyridin-4-yl-4,5-dihydro-1,2-oxazol-5-yl)methanamine Chemical compound O1C(CN)CC(C=2C=CN=CC=2)=N1 UOCPLRLVNRLSHU-UHFFFAOYSA-N 0.000 claims description 3
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 3
125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 3
125000006565 (C4-C7) cyclic group Chemical group 0.000 claims description 3
ZXVWFOMYPHVUGO-UHFFFAOYSA-N 1-(2-methylpropyl)piperidin-4-amine Chemical compound CC(C)CN1CCC(N)CC1 ZXVWFOMYPHVUGO-UHFFFAOYSA-N 0.000 claims description 3
XUKZYTNPGQPSGF-UHFFFAOYSA-N 1-(3-chlorophenyl)indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1C1=CC=CC(Cl)=C1 XUKZYTNPGQPSGF-UHFFFAOYSA-N 0.000 claims description 3
PHYBBHZCDQLDTJ-UHFFFAOYSA-N 1-(3-methoxybenzoyl)indole-2-carboxylic acid Chemical compound COC1=CC=CC(C(=O)N2C3=CC=CC=C3C=C2C(O)=O)=C1 PHYBBHZCDQLDTJ-UHFFFAOYSA-N 0.000 claims description 3
JPSLNYJOGRFEHR-UHFFFAOYSA-N 1-[(1,7-dichloroisoquinolin-3-yl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=CC2=CC=C(Cl)C=C2C(Cl)=N1 JPSLNYJOGRFEHR-UHFFFAOYSA-N 0.000 claims description 3
WSVCZSPRCKBESD-UHFFFAOYSA-N 1-[2-(4-chloroanilino)-2-oxoethyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylic acid Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(O)=O)=CC=C2N1CC(=O)NC1=CC=C(Cl)C=C1 WSVCZSPRCKBESD-UHFFFAOYSA-N 0.000 claims description 3
LSMHPGJCUAQNGL-UHFFFAOYSA-N 1-[2-(4-chlorophenyl)ethyl]-4-methoxy-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC=2C(OC)=CC=CC=2N1CCC1=CC=C(Cl)C=C1 LSMHPGJCUAQNGL-UHFFFAOYSA-N 0.000 claims description 3
OSADXNIFBVARHL-UHFFFAOYSA-N 1-[2-(4-chlorophenyl)ethyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CCC1=CC=C(Cl)C=C1 OSADXNIFBVARHL-UHFFFAOYSA-N 0.000 claims description 3
DBUBLUXPBHYRHZ-UHFFFAOYSA-N 1-[[2-(5-chlorothiophen-2-yl)-1,3-thiazol-5-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=CN=C(C=2SC(Cl)=CC=2)S1 DBUBLUXPBHYRHZ-UHFFFAOYSA-N 0.000 claims description 3
VMMOJOGFBZSURG-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-3-cyanoindole-2-carboxylic acid Chemical compound OC(=O)C1=C(C#N)C2=CC=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 VMMOJOGFBZSURG-UHFFFAOYSA-N 0.000 claims description 3
XVKKWLLVLUJXJU-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4-methyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=C(C)C=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 XVKKWLLVLUJXJU-UHFFFAOYSA-N 0.000 claims description 3
MMGXOGPDBICRQF-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 MMGXOGPDBICRQF-UHFFFAOYSA-N 0.000 claims description 3
UQTLOYNEJNQFNC-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2,5-dicarboxylic acid Chemical compound OC(=O)C1=CC2=CC(C(O)=O)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 UQTLOYNEJNQFNC-UHFFFAOYSA-N 0.000 claims description 3
DKUUFQRZGPJVQO-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,3,4-thiadiazol-2-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylic acid Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(O)=O)=CC=C2N1CC1=NN=C(C=2SC(Cl)=CC=2)S1 DKUUFQRZGPJVQO-UHFFFAOYSA-N 0.000 claims description 3
FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims description 3
FLQSRSQNICPZIH-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-amine Chemical compound CS(=O)(=O)N1CCC(N)CC1 FLQSRSQNICPZIH-UHFFFAOYSA-N 0.000 claims description 3
SYMMPPWYYXRLJX-UHFFFAOYSA-N 1-propan-2-ylpyrrolidin-3-amine Chemical compound CC(C)N1CCC(N)C1 SYMMPPWYYXRLJX-UHFFFAOYSA-N 0.000 claims description 3
ZHKJHQBOAJQXQR-UHFFFAOYSA-N 1H-azirine Chemical compound N1C=C1 ZHKJHQBOAJQXQR-UHFFFAOYSA-N 0.000 claims description 3
AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 claims description 3
RJWLLQWLBMJCFD-UHFFFAOYSA-N 4-methylpiperazin-1-amine Chemical compound CN1CCN(N)CC1 RJWLLQWLBMJCFD-UHFFFAOYSA-N 0.000 claims description 3
GCPRDYGAADRGPV-UHFFFAOYSA-N 5-bromo-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(Br)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 GCPRDYGAADRGPV-UHFFFAOYSA-N 0.000 claims description 3
LPPSTIWITNBFJP-UHFFFAOYSA-N 6-methoxy-1-[(3-methoxyphenyl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC=CC(CN2C3=CC(OC)=CC=C3C=C2C(=O)NC2CCN(CC2)C(C)C)=C1 LPPSTIWITNBFJP-UHFFFAOYSA-N 0.000 claims description 3
206010002388 Angina unstable Diseases 0.000 claims description 3
206010040070 Septic Shock Diseases 0.000 claims description 3
JZFICWYCTCCINF-UHFFFAOYSA-N Thiadiazin Chemical compound S=C1SC(C)NC(C)N1CCN1C(=S)SC(C)NC1C JZFICWYCTCCINF-UHFFFAOYSA-N 0.000 claims description 3
208000007814 Unstable Angina Diseases 0.000 claims description 3
239000003937 drug carrier Substances 0.000 claims description 3
FBXQMKZUDBFFPB-UHFFFAOYSA-N ethyl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylate Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(=O)OCC)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 FBXQMKZUDBFFPB-UHFFFAOYSA-N 0.000 claims description 3
201000004332 intermediate coronary syndrome Diseases 0.000 claims description 3
QJGHUFGKFYHBBN-UHFFFAOYSA-N methyl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylate Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(=O)OC)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 QJGHUFGKFYHBBN-UHFFFAOYSA-N 0.000 claims description 3
OOFGXDQWDNJDIS-UHFFFAOYSA-N oxathiolane Chemical compound C1COSC1 OOFGXDQWDNJDIS-UHFFFAOYSA-N 0.000 claims description 3
JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 claims description 3
230000036303 septic shock Effects 0.000 claims description 3
125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 3
210000003462 vein Anatomy 0.000 claims description 3
JVTMDVFGRFFOOB-UHFFFAOYSA-N (1-pyridin-4-ylpiperidin-4-yl)methanamine Chemical compound C1CC(CN)CCN1C1=CC=NC=C1 JVTMDVFGRFFOOB-UHFFFAOYSA-N 0.000 claims description 2
JJGAYYBQGNJNJQ-UHFFFAOYSA-N 1-(2,2,2-trifluoroethyl)piperidin-4-amine Chemical compound NC1CCN(CC(F)(F)F)CC1 JJGAYYBQGNJNJQ-UHFFFAOYSA-N 0.000 claims description 2
FJTSSHUVCCKRBA-UHFFFAOYSA-N 1-(2-chloropyrimidin-4-yl)piperidin-4-amine Chemical compound C1CC(N)CCN1C1=CC=NC(Cl)=N1 FJTSSHUVCCKRBA-UHFFFAOYSA-N 0.000 claims description 2
XYPXJXNGUNXJSO-UHFFFAOYSA-N 1-[(3,5-dichlorophenyl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=CC(Cl)=CC(Cl)=C1 XYPXJXNGUNXJSO-UHFFFAOYSA-N 0.000 claims description 2
CVPGDWLGSKSTNB-UHFFFAOYSA-N 1-[(3-chlorophenyl)methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC1=CC=CC(Cl)=C1 CVPGDWLGSKSTNB-UHFFFAOYSA-N 0.000 claims description 2
FONDLKIFZSPAPN-UHFFFAOYSA-N 1-[(3-methoxyphenyl)methyl]-5-nitro-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC=CC(CN2C3=CC=C(C=C3C=C2C(=O)NC2CCN(CC2)C(C)C)[N+]([O-])=O)=C1 FONDLKIFZSPAPN-UHFFFAOYSA-N 0.000 claims description 2
ALRWWJBPMNKBTQ-UHFFFAOYSA-N 1-[2-(4-chloroanilino)-2-oxoethyl]-n-(1-cyclopropylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)CN1C2=CC=CC=C2C=C1C(=O)NC1CCN(C2CC2)CC1 ALRWWJBPMNKBTQ-UHFFFAOYSA-N 0.000 claims description 2
UCCPBDBEMMIBRD-UHFFFAOYSA-N 1-[2-(4-chloroanilino)-2-oxoethyl]-n-(1-pyridin-4-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)CN1C2=CC=CC=C2C=C1C(=O)NC1CCN(C=2C=CN=CC=2)CC1 UCCPBDBEMMIBRD-UHFFFAOYSA-N 0.000 claims description 2
RQZVAMABNDVZPG-UHFFFAOYSA-N 1-[2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl]-5,7-difluoro-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(F)=CC(F)=C2N1CC(=O)NC1=CC=C(Cl)C=N1 RQZVAMABNDVZPG-UHFFFAOYSA-N 0.000 claims description 2
LBQLDTXJHMXFGR-UHFFFAOYSA-N 1-[2-[(5-chlorothiophen-2-yl)amino]-2-oxoethyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC(=O)NC1=CC=C(Cl)S1 LBQLDTXJHMXFGR-UHFFFAOYSA-N 0.000 claims description 2
LKOMTXQALRVJGD-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4-(trifluoromethyl)indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=C(C(F)(F)F)C=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 LKOMTXQALRVJGD-UHFFFAOYSA-N 0.000 claims description 2
LSCQITXXLIDIKD-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-(hydroxymethyl)-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(CO)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 LSCQITXXLIDIKD-UHFFFAOYSA-N 0.000 claims description 2
XCOVWRZLKGULFE-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-ethyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(CC)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 XCOVWRZLKGULFE-UHFFFAOYSA-N 0.000 claims description 2
XDHLEMSKBSBEDC-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-cyclopropylpiperidin-4-yl)indole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC2)C2CC2)=NO1 XDHLEMSKBSBEDC-UHFFFAOYSA-N 0.000 claims description 2
ZBYUTHMPEVJBEL-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-ethylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(CC)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 ZBYUTHMPEVJBEL-UHFFFAOYSA-N 0.000 claims description 2
TXFNDLBGYAXFHA-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)-5-(trifluoromethoxy)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(OC(F)(F)F)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 TXFNDLBGYAXFHA-UHFFFAOYSA-N 0.000 claims description 2
WKYZTNUDHMDOAY-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-propylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(CCC)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 WKYZTNUDHMDOAY-UHFFFAOYSA-N 0.000 claims description 2
CNSWKIVXGHMTPX-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(4-pyridin-3-yl-1,3-thiazol-2-yl)indole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NC=2SC=C(N=2)C=2C=NC=CC=2)=NO1 CNSWKIVXGHMTPX-UHFFFAOYSA-N 0.000 claims description 2
UGHLODFEQUSRJG-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-[1-(cyanomethyl)piperidin-4-yl]indole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC#N)CC2)=NO1 UGHLODFEQUSRJG-UHFFFAOYSA-N 0.000 claims description 2
NVPDUERZTNRRHC-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-[1-[2-(dimethylamino)acetyl]piperidin-4-yl]indole-2-carboxamide Chemical compound C1CN(C(=O)CN(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 NVPDUERZTNRRHC-UHFFFAOYSA-N 0.000 claims description 2
HJJXAKRPWXVQGP-UHFFFAOYSA-N 1-cyclopentylpiperidin-4-amine Chemical compound C1CC(N)CCN1C1CCCC1 HJJXAKRPWXVQGP-UHFFFAOYSA-N 0.000 claims description 2
GOLVGZOPWLLUSF-UHFFFAOYSA-N 1-ethylpyrrolidin-3-amine Chemical compound CCN1CCC(N)C1 GOLVGZOPWLLUSF-UHFFFAOYSA-N 0.000 claims description 2
125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
UUNZCNYTZDAYNT-UHFFFAOYSA-N 4,7-dichloro-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=C(Cl)C=CC(Cl)=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 UUNZCNYTZDAYNT-UHFFFAOYSA-N 0.000 claims description 2
OVGNNEOTSYEFRR-UHFFFAOYSA-N 5-methoxy-1-[(3-methoxyphenyl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC=CC(CN2C3=CC=C(OC)C=C3C=C2C(=O)NC2CCN(CC2)C(C)C)=C1 OVGNNEOTSYEFRR-UHFFFAOYSA-N 0.000 claims description 2
125000004008 6 membered carbocyclic group Chemical group 0.000 claims description 2
KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 claims description 2
206010001052 Acute respiratory distress syndrome Diseases 0.000 claims description 2
206010002383 Angina Pectoris Diseases 0.000 claims description 2
208000034486 Multi-organ failure Diseases 0.000 claims description 2
206010028980 Neoplasm Diseases 0.000 claims description 2
101100258328 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) crc-2 gene Proteins 0.000 claims description 2
208000010378 Pulmonary Embolism Diseases 0.000 claims description 2
208000013616 Respiratory Distress Syndrome Diseases 0.000 claims description 2
208000006011 Stroke Diseases 0.000 claims description 2
208000036142 Viral infection Diseases 0.000 claims description 2
BBIKJABFWABRCZ-UHFFFAOYSA-N [1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-7-methylindol-2-yl]-[4-(propan-2-ylamino)piperidin-1-yl]methanone Chemical compound C1CC(NC(C)C)CCN1C(=O)C1=CC2=CC=CC(C)=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 BBIKJABFWABRCZ-UHFFFAOYSA-N 0.000 claims description 2
MGRCNGCGYRBCHN-UHFFFAOYSA-N [1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indol-2-yl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)N2CCC(CC2)N2CCCC2)=NO1 MGRCNGCGYRBCHN-UHFFFAOYSA-N 0.000 claims description 2
HAHDTUXAQNSETN-UHFFFAOYSA-N [1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indol-2-yl]-[4-(propan-2-ylamino)piperidin-1-yl]methanone Chemical compound C1CC(NC(C)C)CCN1C(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 HAHDTUXAQNSETN-UHFFFAOYSA-N 0.000 claims description 2
RIWBBCOZKYZGPE-UHFFFAOYSA-N [1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indol-2-yl]-[4-(pyridin-4-ylmethyl)piperazin-1-yl]methanone Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)N2CCN(CC=3C=CN=CC=3)CC2)=NO1 RIWBBCOZKYZGPE-UHFFFAOYSA-N 0.000 claims description 2
230000003187 abdominal effect Effects 0.000 claims description 2
230000002159 abnormal effect Effects 0.000 claims description 2
208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims description 2
201000000028 adult respiratory distress syndrome Diseases 0.000 claims description 2
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 2
201000011510 cancer Diseases 0.000 claims description 2
208000029078 coronary artery disease Diseases 0.000 claims description 2
125000000753 cycloalkyl group Chemical group 0.000 claims description 2
210000003127 knee Anatomy 0.000 claims description 2
210000003141 lower extremity Anatomy 0.000 claims description 2
208000029744 multiple organ dysfunction syndrome Diseases 0.000 claims description 2
208000010125 myocardial infarction Diseases 0.000 claims description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
230000009885 systemic effect Effects 0.000 claims description 2
230000001052 transient effect Effects 0.000 claims description 2
230000009385 viral infection Effects 0.000 claims description 2
ROYKQAJQFZWJBU-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-nitroindole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC([N+]([O-])=O)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 ROYKQAJQFZWJBU-UHFFFAOYSA-N 0.000 claims 4
SGPGESCZOCHFCL-UHFFFAOYSA-N Tilisolol hydrochloride Chemical compound [Cl-].C1=CC=C2C(=O)N(C)C=C(OCC(O)C[NH2+]C(C)(C)C)C2=C1 SGPGESCZOCHFCL-UHFFFAOYSA-N 0.000 claims 4
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 3
OGZPXUGZOKKVSQ-UHFFFAOYSA-N 1-[(2,4-dichlorophenyl)methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC1=CC=C(Cl)C=C1Cl OGZPXUGZOKKVSQ-UHFFFAOYSA-N 0.000 claims 2
UDFMDSBCVQSAMH-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]indole-2-carboxylic acid Chemical compound C1=CC(OC)=CC=C1CN1C2=CC=CC=C2C=C1C(O)=O UDFMDSBCVQSAMH-UHFFFAOYSA-N 0.000 claims 2
BBOTYKYSYRSDPL-UHFFFAOYSA-N 1-[[3-(4-chlorophenyl)-1,2-oxazol-5-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=CC(C=2C=CC(Cl)=CC=2)=NO1 BBOTYKYSYRSDPL-UHFFFAOYSA-N 0.000 claims 2
NBRCEBZBAGMRKS-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-3-phenyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C(N(C1=CC=CC=C11)CC2=NOC(=C2)C=2SC(Cl)=CC=2)=C1C1=CC=CC=C1 NBRCEBZBAGMRKS-UHFFFAOYSA-N 0.000 claims 2
UUWXQABINFEYRX-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4,7-dimethyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=C(C)C=CC(C)=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 UUWXQABINFEYRX-UHFFFAOYSA-N 0.000 claims 2
ZBISMVFPTGJSFE-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4-methoxyindole-2-carboxylic acid Chemical compound OC(=O)C1=CC=2C(OC)=CC=CC=2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 ZBISMVFPTGJSFE-UHFFFAOYSA-N 0.000 claims 2
AXCCESLSZJMAOY-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5,6-dimethoxy-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1=C(C=2SC(Cl)=CC=2)ON=C1CN1C=2C=C(OC)C(OC)=CC=2C=C1C(=O)NC1CCN(C(C)C)CC1 AXCCESLSZJMAOY-UHFFFAOYSA-N 0.000 claims 2
HVXGKULGUMYXQN-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-fluoroindole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC(F)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 HVXGKULGUMYXQN-UHFFFAOYSA-N 0.000 claims 2
ZYDBCOCZMCTCTF-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-methoxyindole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC(OC)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 ZYDBCOCZMCTCTF-UHFFFAOYSA-N 0.000 claims 2
PDQRSJNOSOOSON-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-6-methoxyindole-2-carboxylic acid Chemical compound C12=CC(OC)=CC=C2C=C(C(O)=O)N1CC(=NO1)C=C1C1=CC=C(Cl)S1 PDQRSJNOSOOSON-UHFFFAOYSA-N 0.000 claims 2
CENKJXADYBDCLM-UHFFFAOYSA-N 4-(1h-imidazol-5-yl)aniline Chemical compound C1=CC(N)=CC=C1C1=CNC=N1 CENKJXADYBDCLM-UHFFFAOYSA-N 0.000 claims 2
QTSFZRYBFQUMFY-UHFFFAOYSA-N 4-bromo-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=C(Br)C=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 QTSFZRYBFQUMFY-UHFFFAOYSA-N 0.000 claims 2
VZGXXNKOVRJPAJ-UHFFFAOYSA-N 4-chloro-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=C(Cl)C=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 VZGXXNKOVRJPAJ-UHFFFAOYSA-N 0.000 claims 2
AEOMOQMOFDQVQH-UHFFFAOYSA-N 4-methoxy-1-[(3-methoxyphenyl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC=CC(CN2C3=CC=CC(OC)=C3C=C2C(=O)NC2CCN(CC2)C(C)C)=C1 AEOMOQMOFDQVQH-UHFFFAOYSA-N 0.000 claims 2
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 2
239000005977 Ethylene Substances 0.000 claims 2
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 claims 2
JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 claims 1
125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 1
QNPLMTSDLDXJOJ-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-n-(1-pyridin-4-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound ClC1=CC=CC=C1CN1C2=CC=CC=C2C=C1C(=O)NC1CCN(C=2C=CN=CC=2)CC1 QNPLMTSDLDXJOJ-UHFFFAOYSA-N 0.000 claims 1
WGJDALZUNVBQGQ-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-n-[(1-pyridin-4-ylpiperidin-4-yl)methyl]indole-2-carboxamide Chemical compound ClC1=CC=CC=C1CN1C2=CC=CC=C2C=C1C(=O)NCC1CCN(C=2C=CN=CC=2)CC1 WGJDALZUNVBQGQ-UHFFFAOYSA-N 0.000 claims 1
KDMMRRCLTYHTRA-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC1=CC=CC=C1Cl KDMMRRCLTYHTRA-UHFFFAOYSA-N 0.000 claims 1
MNPACACYUKHVSF-UHFFFAOYSA-N 1-[(3-methoxyphenyl)methyl]-5-methylindole-2-carboxylic acid Chemical compound COC1=CC=CC(CN2C3=CC=C(C)C=C3C=C2C(O)=O)=C1 MNPACACYUKHVSF-UHFFFAOYSA-N 0.000 claims 1
BZVBYLVMDFQPPO-UHFFFAOYSA-N 1-[(3-methoxyphenyl)methyl]-5-phenylmethoxyindole-2-carboxylic acid Chemical compound COC1=CC=CC(CN2C3=CC=C(OCC=4C=CC=CC=4)C=C3C=C2C(O)=O)=C1 BZVBYLVMDFQPPO-UHFFFAOYSA-N 0.000 claims 1
NVNHLHARFHSBHN-UHFFFAOYSA-N 1-[(3-methoxyphenyl)methyl]-n-[(1-pyridin-4-ylpiperidin-4-yl)methyl]indole-2-carboxamide Chemical compound COC1=CC=CC(CN2C3=CC=CC=C3C=C2C(=O)NCC2CCN(CC2)C=2C=CN=CC=2)=C1 NVNHLHARFHSBHN-UHFFFAOYSA-N 0.000 claims 1
AVAVKXFPPIKFLU-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)ethyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CCC1=CC=C(Cl)C=C1Cl AVAVKXFPPIKFLU-UHFFFAOYSA-N 0.000 claims 1
QZHQPTPQLDIMDW-UHFFFAOYSA-N 1-[2-(3-methoxyphenyl)ethyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC=CC(CCN2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC2)C(C)C)=C1 QZHQPTPQLDIMDW-UHFFFAOYSA-N 0.000 claims 1
RSSZOVHMWPWHRW-UHFFFAOYSA-N 1-[2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl]-5,7-difluoroindole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC(F)=CC(F)=C2N1CC(=O)NC1=CC=C(Cl)C=N1 RSSZOVHMWPWHRW-UHFFFAOYSA-N 0.000 claims 1
BQJDWODPYFMLRF-UHFFFAOYSA-N 1-[2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl]-5-fluoro-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(F)=CC=C2N1CC(=O)NC1=CC=C(Cl)C=N1 BQJDWODPYFMLRF-UHFFFAOYSA-N 0.000 claims 1
MEXORDHFWBGICH-UHFFFAOYSA-N 1-[2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC(=O)NC1=CC=C(Cl)C=N1 MEXORDHFWBGICH-UHFFFAOYSA-N 0.000 claims 1
BXFXPFGAFHCTJK-UHFFFAOYSA-N 1-[[5-(4-chlorophenyl)-1,2-oxazol-3-yl]methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)C=C1 BXFXPFGAFHCTJK-UHFFFAOYSA-N 0.000 claims 1
MCLVKEPZVPUETD-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-3-cyano-7-methyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=C(C#N)C2=CC=CC(C)=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 MCLVKEPZVPUETD-UHFFFAOYSA-N 0.000 claims 1
IFYZNYDATSTMIF-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-3-fluoroindole-2-carboxylic acid Chemical compound OC(=O)C1=C(F)C2=CC=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 IFYZNYDATSTMIF-UHFFFAOYSA-N 0.000 claims 1
QJEVVAJVLUWEQH-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4,7-dimethoxy-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC=2C(OC)=CC=C(OC)C=2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 QJEVVAJVLUWEQH-UHFFFAOYSA-N 0.000 claims 1
WQLXVHXEIKYATP-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4-phenylmethoxy-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C(N(C1=CC=C2)CC3=NOC(=C3)C=3SC(Cl)=CC=3)=CC1=C2OCC1=CC=CC=C1 WQLXVHXEIKYATP-UHFFFAOYSA-N 0.000 claims 1
SPWFDCRQUSGLEI-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-(trifluoromethoxy)indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC(OC(F)(F)F)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 SPWFDCRQUSGLEI-UHFFFAOYSA-N 0.000 claims 1
MIAKKEUDIJWLRS-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-methylindole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC(C)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 MIAKKEUDIJWLRS-UHFFFAOYSA-N 0.000 claims 1
ZEDLOMWFPPHULL-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-methylsulfonyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(S(C)(=O)=O)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 ZEDLOMWFPPHULL-UHFFFAOYSA-N 0.000 claims 1
VJPZUXGTAPECIE-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-6-hydroxy-5-methoxy-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1=C(C=2SC(Cl)=CC=2)ON=C1CN1C=2C=C(O)C(OC)=CC=2C=C1C(=O)NC1CCN(C(C)C)CC1 VJPZUXGTAPECIE-UHFFFAOYSA-N 0.000 claims 1
FZIDKOXFABWJKQ-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-7-nitro-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC([N+]([O-])=O)=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 FZIDKOXFABWJKQ-UHFFFAOYSA-N 0.000 claims 1
GZYLKYFEFKEDRG-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-methylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 GZYLKYFEFKEDRG-UHFFFAOYSA-N 0.000 claims 1
SVJYWBCZJYRMOV-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)-4-(trifluoromethyl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=C(C(F)(F)F)C=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 SVJYWBCZJYRMOV-UHFFFAOYSA-N 0.000 claims 1
YXKCQZAYGJLSQA-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(4-propan-2-ylpiperazin-1-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCN1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 YXKCQZAYGJLSQA-UHFFFAOYSA-N 0.000 claims 1
DHCMYQUCCIZFNC-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-[(3-pyridin-4-yl-4,5-dihydro-1,2-oxazol-5-yl)methyl]indole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NCC2ON=C(C2)C=2C=CN=CC=2)=NO1 DHCMYQUCCIZFNC-UHFFFAOYSA-N 0.000 claims 1
LQECDCSJZMOPNM-UHFFFAOYSA-N 1-cyclohexyloxycarbonyloxyethyl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylate Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(=O)OC(C)OC(=O)OC3CCCCC3)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 LQECDCSJZMOPNM-UHFFFAOYSA-N 0.000 claims 1
SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 claims 1
ZGYLBJLUOKJLRB-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)acetonitrile Chemical compound NC1CCN(CC#N)CC1 ZGYLBJLUOKJLRB-UHFFFAOYSA-N 0.000 claims 1
125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
GVRBMDIVXNBXEK-UHFFFAOYSA-N 4-ethylpiperidin-4-amine Chemical compound CCC1(N)CCNCC1 GVRBMDIVXNBXEK-UHFFFAOYSA-N 0.000 claims 1
DGAMIPORAILRPW-UHFFFAOYSA-N 5-chloro-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(Cl)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 DGAMIPORAILRPW-UHFFFAOYSA-N 0.000 claims 1
206010053567 Coagulopathies Diseases 0.000 claims 1
HBHIIHHLSZNUAT-UHFFFAOYSA-N [1-[(3-methoxyphenyl)methyl]indol-2-yl]-[4-(pyridin-4-ylamino)piperidin-1-yl]methanone Chemical compound COC1=CC=CC(CN2C3=CC=CC=C3C=C2C(=O)N2CCC(CC2)NC=2C=CN=CC=2)=C1 HBHIIHHLSZNUAT-UHFFFAOYSA-N 0.000 claims 1
238000007887 coronary angioplasty Methods 0.000 claims 1
JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims 1
JCISJJATYPEPNN-UHFFFAOYSA-N ethyl 2-[[1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4-(trifluoromethyl)indole-2-carbonyl]-(1-propan-2-ylpiperidin-4-yl)amino]acetate Chemical compound C=1C2=C(C(F)(F)F)C=CC=C2N(CC2=NOC(=C2)C=2SC(Cl)=CC=2)C=1C(=O)N(CC(=O)OCC)C1CCN(C(C)C)CC1 JCISJJATYPEPNN-UHFFFAOYSA-N 0.000 claims 1
125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 claims 1
230000002107 myocardial effect Effects 0.000 claims 1
GLLJZAWLZCAMDT-UHFFFAOYSA-N n-(1-acetylpiperidin-4-yl)-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carboxamide Chemical compound C1CN(C(=O)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 GLLJZAWLZCAMDT-UHFFFAOYSA-N 0.000 claims 1
DNLIPQVJNZNUCJ-UHFFFAOYSA-N n-(1-carbamoylpiperidin-4-yl)-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carboxamide Chemical compound C1CN(C(=O)N)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 DNLIPQVJNZNUCJ-UHFFFAOYSA-N 0.000 claims 1
230000004044 response Effects 0.000 claims 1
108010074860 Factor Xa Proteins 0.000 abstract description 42
230000000694 effects Effects 0.000 abstract description 19
230000002441 reversible effect Effects 0.000 abstract description 15
238000011321 prophylaxis Methods 0.000 abstract description 11
239000003112 inhibitor Substances 0.000 abstract description 7
230000002785 anti-thrombosis Effects 0.000 abstract description 2
108010054265 Factor VIIa Proteins 0.000 abstract 4
229940012414 factor viia Drugs 0.000 abstract 4
239000004480 active ingredient Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
125000001309 chloro group Chemical group Cl* 0.000 description 218
239000000243 solution Substances 0.000 description 140
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 124
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 119
230000002829 reductive effect Effects 0.000 description 116
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 102
239000000047 product Substances 0.000 description 99
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 90
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 89
DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 89
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 85
239000002904 solvent Substances 0.000 description 78
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 61
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 57
238000000524 positive electrospray ionisation mass spectrometry Methods 0.000 description 56
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 52
ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 52
238000006243 chemical reaction Methods 0.000 description 50
239000007787 solid Substances 0.000 description 42
239000011541 reaction mixture Substances 0.000 description 39
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 37
229940093499 ethyl acetate Drugs 0.000 description 34
235000019439 ethyl acetate Nutrition 0.000 description 34
DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 33
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 29
WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 29
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 28
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 28
238000005160 1H NMR spectroscopy Methods 0.000 description 26
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 26
238000003786 synthesis reaction Methods 0.000 description 26
229940002612 prodrug Drugs 0.000 description 25
239000000651 prodrug Substances 0.000 description 25
239000000741 silica gel Substances 0.000 description 25
229910002027 silica gel Inorganic materials 0.000 description 25
238000003756 stirring Methods 0.000 description 22
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
238000004108 freeze drying Methods 0.000 description 21
125000001424 substituent group Chemical group 0.000 description 21
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 20
HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 description 20
238000007792 addition Methods 0.000 description 20
238000004587 chromatography analysis Methods 0.000 description 20
238000010828 elution Methods 0.000 description 20
238000004007 reversed phase HPLC Methods 0.000 description 20
239000007858 starting material Substances 0.000 description 19
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 18
239000012044 organic layer Substances 0.000 description 18
UBIXPIXAVFHKMM-UHFFFAOYSA-N 3-(bromomethyl)-5-(5-chlorothiophen-2-yl)-1,2-oxazole Chemical compound S1C(Cl)=CC=C1C1=CC(CBr)=NO1 UBIXPIXAVFHKMM-UHFFFAOYSA-N 0.000 description 17
238000004128 high performance liquid chromatography Methods 0.000 description 17
239000012071 phase Substances 0.000 description 17
238000000746 purification Methods 0.000 description 17
238000001914 filtration Methods 0.000 description 16
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 15
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
238000003556 assay Methods 0.000 description 12
239000003795 chemical substances by application Substances 0.000 description 11
239000000725 suspension Substances 0.000 description 11
125000000623 heterocyclic group Chemical group 0.000 description 10
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
229910052786 argon Inorganic materials 0.000 description 9
239000003153 chemical reaction reagent Substances 0.000 description 9
239000003921 oil Substances 0.000 description 9
235000019198 oils Nutrition 0.000 description 9
239000002244 precipitate Substances 0.000 description 9
KLDLRDSRCMJKGM-UHFFFAOYSA-N 3-[chloro-(2-oxo-1,3-oxazolidin-3-yl)phosphoryl]-1,3-oxazolidin-2-one Chemical compound C1COC(=O)N1P(=O)(Cl)N1CCOC1=O KLDLRDSRCMJKGM-UHFFFAOYSA-N 0.000 description 8
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 8
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
238000005804 alkylation reaction Methods 0.000 description 8
150000001412 amines Chemical class 0.000 description 8
125000004093 cyano group Chemical group *C#N 0.000 description 8
150000002475 indoles Chemical class 0.000 description 8
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 8
YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 7
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
235000011054 acetic acid Nutrition 0.000 description 7
150000007513 acids Chemical class 0.000 description 7
125000002252 acyl group Chemical group 0.000 description 7
230000029936 alkylation Effects 0.000 description 7
230000002401 inhibitory effect Effects 0.000 description 7
125000006239 protecting group Chemical group 0.000 description 7
239000011734 sodium Substances 0.000 description 7
KBXWLAQHWUNMMX-UHFFFAOYSA-N 1-(4-methoxyphenyl)indole-2-carboxylic acid Chemical compound C1=CC(OC)=CC=C1N1C2=CC=CC=C2C=C1C(O)=O KBXWLAQHWUNMMX-UHFFFAOYSA-N 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 6
FPQVGDGSRVMNMR-JCTPKUEWSA-N [[(z)-(1-cyano-2-ethoxy-2-oxoethylidene)amino]oxy-(dimethylamino)methylidene]-dimethylazanium;tetrafluoroborate Chemical compound F[B-](F)(F)F.CCOC(=O)C(\C#N)=N/OC(N(C)C)=[N+](C)C FPQVGDGSRVMNMR-JCTPKUEWSA-N 0.000 description 6
125000003277 amino group Chemical group 0.000 description 6
238000001816 cooling Methods 0.000 description 6
239000003480 eluent Substances 0.000 description 6
229940088598 enzyme Drugs 0.000 description 6
125000004185 ester group Chemical group 0.000 description 6
QQXQAEWRSVZPJM-UHFFFAOYSA-N ethyl 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)OCC)=CC2=C1 QQXQAEWRSVZPJM-UHFFFAOYSA-N 0.000 description 6
239000006260 foam Substances 0.000 description 6
229910052763 palladium Inorganic materials 0.000 description 6
125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 6
229920001223 polyethylene glycol Polymers 0.000 description 6
238000006268 reductive amination reaction Methods 0.000 description 6
229910052938 sodium sulfate Inorganic materials 0.000 description 6
235000011152 sodium sulphate Nutrition 0.000 description 6
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 5
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 5
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
210000004369 blood Anatomy 0.000 description 5
239000008280 blood Substances 0.000 description 5
125000002843 carboxylic acid group Chemical group 0.000 description 5
150000001735 carboxylic acids Chemical class 0.000 description 5
125000004494 ethyl ester group Chemical group 0.000 description 5
239000012074 organic phase Substances 0.000 description 5
125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 5
BCIIMDOZSUCSEN-UHFFFAOYSA-N piperidin-4-amine Chemical compound NC1CCNCC1 BCIIMDOZSUCSEN-UHFFFAOYSA-N 0.000 description 5
125000003367 polycyclic group Chemical group 0.000 description 5
239000012312 sodium hydride Substances 0.000 description 5
229910000104 sodium hydride Inorganic materials 0.000 description 5
238000010561 standard procedure Methods 0.000 description 5
239000000126 substance Substances 0.000 description 5
239000003826 tablet Substances 0.000 description 5
238000011282 treatment Methods 0.000 description 5
VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 4
KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 4
VTVNGWNXLGINQY-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-piperidin-4-ylindole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NC2CCNCC2)=NO1 VTVNGWNXLGINQY-UHFFFAOYSA-N 0.000 description 4
SATKWGUTVPCWFY-UHFFFAOYSA-N 1-bromoethyl 2,2-dimethylpropanoate Chemical compound CC(Br)OC(=O)C(C)(C)C SATKWGUTVPCWFY-UHFFFAOYSA-N 0.000 description 4
YSTUPBOIUOUMHG-UHFFFAOYSA-N 2-bromo-n-(4-chlorophenyl)acetamide Chemical compound ClC1=CC=C(NC(=O)CBr)C=C1 YSTUPBOIUOUMHG-UHFFFAOYSA-N 0.000 description 4
HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 4
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
101100134927 Gallus gallus COR8 gene Proteins 0.000 description 4
239000007832 Na2SO4 Substances 0.000 description 4
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
108010000499 Thromboplastin Proteins 0.000 description 4
102000002262 Thromboplastin Human genes 0.000 description 4
125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 4
125000002015 acyclic group Chemical group 0.000 description 4
238000002399 angioplasty Methods 0.000 description 4
239000003130 blood coagulation factor inhibitor Substances 0.000 description 4
ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 4
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 4
150000001721 carbon Chemical group 0.000 description 4
239000000969 carrier Substances 0.000 description 4
230000003197 catalytic effect Effects 0.000 description 4
125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 4
125000004043 oxo group Chemical group O=* 0.000 description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
239000000758 substrate Substances 0.000 description 4
FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 4
CKXZPVPIDOJLLM-UHFFFAOYSA-N tert-butyl n-piperidin-4-ylcarbamate Chemical compound CC(C)(C)OC(=O)NC1CCNCC1 CKXZPVPIDOJLLM-UHFFFAOYSA-N 0.000 description 4
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
RPXARQCXLPPUMJ-UHFFFAOYSA-N 1-[2-(4-chloroanilino)-2-oxoethyl]-n-[(1-pyridin-4-ylpiperidin-4-yl)methyl]indole-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)CN1C2=CC=CC=C2C=C1C(=O)NCC1CCN(C=2C=CN=CC=2)CC1 RPXARQCXLPPUMJ-UHFFFAOYSA-N 0.000 description 3
KXIXHISTUVHOCY-UHFFFAOYSA-N 1-propan-2-ylpiperidine Chemical compound CC(C)N1CCCCC1 KXIXHISTUVHOCY-UHFFFAOYSA-N 0.000 description 3
REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 3
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
208000032843 Hemorrhage Diseases 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
238000010716 Reissert indole synthesis reaction Methods 0.000 description 3
108090000190 Thrombin Proteins 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
150000008064 anhydrides Chemical class 0.000 description 3
229940127219 anticoagulant drug Drugs 0.000 description 3
239000002585 base Substances 0.000 description 3
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 3
208000034158 bleeding Diseases 0.000 description 3
230000000740 bleeding effect Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 3
239000003054 catalyst Substances 0.000 description 3
GGRHYQCXXYLUTL-UHFFFAOYSA-N chloromethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCl GGRHYQCXXYLUTL-UHFFFAOYSA-N 0.000 description 3
125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000015271 coagulation Effects 0.000 description 3
238000005345 coagulation Methods 0.000 description 3
239000010949 copper Substances 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
229940079593 drug Drugs 0.000 description 3
238000001035 drying Methods 0.000 description 3
PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 3
239000007903 gelatin capsule Substances 0.000 description 3
125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
150000002476 indolines Chemical class 0.000 description 3
229910052740 iodine Inorganic materials 0.000 description 3
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 3
229940040692 lithium hydroxide monohydrate Drugs 0.000 description 3
GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
OJQRSXICVBYQNF-UHFFFAOYSA-N propan-2-yl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylate Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(=O)OC(C)C)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 OJQRSXICVBYQNF-UHFFFAOYSA-N 0.000 description 3
239000000523 sample Substances 0.000 description 3
238000007127 saponification reaction Methods 0.000 description 3
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
239000007790 solid phase Substances 0.000 description 3
IDPAGRMFQKXGMZ-UHFFFAOYSA-N tert-butyl n-[1-(2-chloropyrimidin-4-yl)piperidin-4-yl]carbamate Chemical compound C1CC(NC(=O)OC(C)(C)C)CCN1C1=CC=NC(Cl)=N1 IDPAGRMFQKXGMZ-UHFFFAOYSA-N 0.000 description 3
229960004072 thrombin Drugs 0.000 description 3
229910052723 transition metal Inorganic materials 0.000 description 3
150000003624 transition metals Chemical class 0.000 description 3
ICIJWOWQUHHETJ-UHFFFAOYSA-N (3,5-dichlorophenyl)methanamine Chemical compound NCC1=CC(Cl)=CC(Cl)=C1 ICIJWOWQUHHETJ-UHFFFAOYSA-N 0.000 description 2
ILJYDQMZEQMUBB-UHFFFAOYSA-N (4-pyridin-4-ylphenyl)methanamine Chemical compound C1=CC(CN)=CC=C1C1=CC=NC=C1 ILJYDQMZEQMUBB-UHFFFAOYSA-N 0.000 description 2
UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
BVSIBCJUGIVAKQ-UHFFFAOYSA-N 1-(3-methoxyphenyl)-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC=CC(N2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC2)C(C)C)=C1 BVSIBCJUGIVAKQ-UHFFFAOYSA-N 0.000 description 2
LIWWTXDXKPVJAU-UHFFFAOYSA-N 1-(3-methoxyphenyl)sulfonyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC=CC(S(=O)(=O)N2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC2)C(C)C)=C1 LIWWTXDXKPVJAU-UHFFFAOYSA-N 0.000 description 2
UQUFONQTPPAJAO-UHFFFAOYSA-N 1-(4-methoxyphenyl)-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1=CC(OC)=CC=C1N1C2=CC=CC=C2C=C1C(=O)NC1CCN(C(C)C)CC1 UQUFONQTPPAJAO-UHFFFAOYSA-N 0.000 description 2
DLMIMIWKEZCOGZ-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)ethyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CCC1=CC=C(Cl)C=C1Cl DLMIMIWKEZCOGZ-UHFFFAOYSA-N 0.000 description 2
DSBLCMAHBANTAE-UHFFFAOYSA-N 1-[2-(3-methoxyphenyl)ethyl]indole-2-carboxylic acid Chemical compound COC1=CC=CC(CCN2C3=CC=CC=C3C=C2C(O)=O)=C1 DSBLCMAHBANTAE-UHFFFAOYSA-N 0.000 description 2
TUJRINRCZRSTKI-UHFFFAOYSA-N 1-[2-(4-chloro-2-fluoroanilino)-2-oxoethyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC(=O)NC1=CC=C(Cl)C=C1F TUJRINRCZRSTKI-UHFFFAOYSA-N 0.000 description 2
STBWXHLSTUVZGW-UHFFFAOYSA-N 1-[2-(4-chloroanilino)-2-oxoethyl]-5-methylsulfonyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(S(C)(=O)=O)=CC=C2N1CC(=O)NC1=CC=C(Cl)C=C1 STBWXHLSTUVZGW-UHFFFAOYSA-N 0.000 description 2
AXJHGZQKOZQHQC-UHFFFAOYSA-N 1-[2-(4-chloroanilino)-2-oxoethyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC(=O)NC1=CC=C(Cl)C=C1 AXJHGZQKOZQHQC-UHFFFAOYSA-N 0.000 description 2
QOTVVZPQBGZYFT-UHFFFAOYSA-N 1-[2-(4-chlorophenyl)ethyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CCC1=CC=C(Cl)C=C1 QOTVVZPQBGZYFT-UHFFFAOYSA-N 0.000 description 2
ILRJJEMRKWAJMZ-UHFFFAOYSA-N 1-[2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC(=O)NC1=CC=C(Cl)C=N1 ILRJJEMRKWAJMZ-UHFFFAOYSA-N 0.000 description 2
125000001478 1-chloroethyl group Chemical group [H]C([H])([H])C([H])(Cl)* 0.000 description 2
AZAOSUQSSRSEPV-UHFFFAOYSA-N 1-cyclohexyloxycarbonyloxyethyl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-4-carboxylate Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=C(C(=O)OC(C)OC(=O)OC3CCCCC3)C=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 AZAOSUQSSRSEPV-UHFFFAOYSA-N 0.000 description 2
XQRNOQYMHPJDCY-UHFFFAOYSA-N 1-cyclopropylpiperidin-4-amine Chemical compound C1CC(N)CCN1C1CC1 XQRNOQYMHPJDCY-UHFFFAOYSA-N 0.000 description 2
UFETTXCVHFVMPU-UHFFFAOYSA-N 1-ethylpiperidin-4-amine Chemical compound CCN1CCC(N)CC1 UFETTXCVHFVMPU-UHFFFAOYSA-N 0.000 description 2
125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 2
SKZUXKOWTWFPPH-UHFFFAOYSA-N 1-propan-2-ylpiperidin-4-amine;hydrochloride Chemical compound Cl.CC(C)N1CCC(N)CC1 SKZUXKOWTWFPPH-UHFFFAOYSA-N 0.000 description 2
BDLMBQRBNPDCSS-UHFFFAOYSA-N 1-{2-[(4-chlorophenyl)amino]-2-oxoethyl}-n-(1-isopropylpiperidin-4-yl)-1h-indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC(=O)NC1=CC=C(Cl)C=C1 BDLMBQRBNPDCSS-UHFFFAOYSA-N 0.000 description 2
PAQZWJGSJMLPMG-UHFFFAOYSA-N 2,4,6-tripropyl-1,3,5,2$l^{5},4$l^{5},6$l^{5}-trioxatriphosphinane 2,4,6-trioxide Chemical compound CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 PAQZWJGSJMLPMG-UHFFFAOYSA-N 0.000 description 2
NMWIFNPFFNFXPB-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)ethanol Chemical compound NC1CCN(CCO)CC1 NMWIFNPFFNFXPB-UHFFFAOYSA-N 0.000 description 2
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
XYYIHBSYADINEC-UHFFFAOYSA-N 2-bromo-n-(5-chloropyridin-2-yl)acetamide Chemical compound ClC1=CC=C(NC(=O)CBr)N=C1 XYYIHBSYADINEC-UHFFFAOYSA-N 0.000 description 2
OGYYPBLWGAEIRF-UHFFFAOYSA-N 2-o-ethyl 5-o-propan-2-yl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2,5-dicarboxylate Chemical compound CCOC(=O)C1=CC2=CC(C(=O)OC(C)C)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 OGYYPBLWGAEIRF-UHFFFAOYSA-N 0.000 description 2
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 2
125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 2
IHERZVGWOOXGGV-UHFFFAOYSA-N 4-aminopiperidine-1-carbaldehyde Chemical compound NC1CCN(C=O)CC1 IHERZVGWOOXGGV-UHFFFAOYSA-N 0.000 description 2
QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 2
PVMNPAUTCMBOMO-UHFFFAOYSA-N 4-chloropyridine Chemical compound ClC1=CC=NC=C1 PVMNPAUTCMBOMO-UHFFFAOYSA-N 0.000 description 2
XGAFCCUNHIMIRV-UHFFFAOYSA-N 4-chloropyridine;hydron;chloride Chemical compound Cl.ClC1=CC=NC=C1 XGAFCCUNHIMIRV-UHFFFAOYSA-N 0.000 description 2
229960000549 4-dimethylaminophenol Drugs 0.000 description 2
ZZAVIQXQBBOHBB-UHFFFAOYSA-N 4-methoxy-1h-indole-2-carboxylic acid Chemical compound COC1=CC=CC2=C1C=C(C(O)=O)N2 ZZAVIQXQBBOHBB-UHFFFAOYSA-N 0.000 description 2
YAULOOYNCJDPPU-UHFFFAOYSA-N 5-bromo-1h-indole-2-carboxylic acid Chemical compound BrC1=CC=C2NC(C(=O)O)=CC2=C1 YAULOOYNCJDPPU-UHFFFAOYSA-N 0.000 description 2
VHJNNWZGANFTEB-UHFFFAOYSA-N 5-chloro-1-[(3-methoxyphenyl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC=CC(CN2C3=CC=C(Cl)C=C3C=C2C(=O)NC2CCN(CC2)C(C)C)=C1 VHJNNWZGANFTEB-UHFFFAOYSA-N 0.000 description 2
MAXBVGJEFDMHNV-UHFFFAOYSA-N 5-chloropyridin-2-amine Chemical compound NC1=CC=C(Cl)C=N1 MAXBVGJEFDMHNV-UHFFFAOYSA-N 0.000 description 2
LHFOJSCXLFKDIR-UHFFFAOYSA-N 5-nitro-1h-indole-2-carboxylic acid Chemical compound [O-][N+](=O)C1=CC=C2NC(C(=O)O)=CC2=C1 LHFOJSCXLFKDIR-UHFFFAOYSA-N 0.000 description 2
XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 2
XNBGANWAZJWOHS-UHFFFAOYSA-N 6-methoxy-1h-indole-2-carboxylic acid Chemical compound COC1=CC=C2C=C(C(O)=O)NC2=C1 XNBGANWAZJWOHS-UHFFFAOYSA-N 0.000 description 2
WFWYWVZGUUCHBL-UHFFFAOYSA-N 7-(aminomethyl)quinazolin-4-amine Chemical compound NC1=NC=NC2=CC(CN)=CC=C21 WFWYWVZGUUCHBL-UHFFFAOYSA-N 0.000 description 2
OLNYNTKNRVFVBI-UHFFFAOYSA-N 7-methyl-1h-indole-2-carboxylic acid Chemical compound CC1=CC=CC2=C1NC(C(O)=O)=C2 OLNYNTKNRVFVBI-UHFFFAOYSA-N 0.000 description 2
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
238000007126 N-alkylation reaction Methods 0.000 description 2
PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
150000001204 N-oxides Chemical class 0.000 description 2
238000006789 Nenitzescu synthesis reaction Methods 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 2
239000004365 Protease Substances 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
238000006619 Stille reaction Methods 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
230000009471 action Effects 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
206010000891 acute myocardial infarction Diseases 0.000 description 2
238000005576 amination reaction Methods 0.000 description 2
238000013459 approach Methods 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
238000006254 arylation reaction Methods 0.000 description 2
YVBGFNPXYFYEIX-UHFFFAOYSA-N benzyl 1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]indole-2-carboxylate Chemical compound C=1C2=CC=CC=C2N(CC(=O)OC(C)(C)C)C=1C(=O)OCC1=CC=CC=C1 YVBGFNPXYFYEIX-UHFFFAOYSA-N 0.000 description 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
239000012267 brine Substances 0.000 description 2
239000011575 calcium Substances 0.000 description 2
125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
238000006555 catalytic reaction Methods 0.000 description 2
150000001805 chlorine compounds Chemical class 0.000 description 2
VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 2
229910052802 copper Inorganic materials 0.000 description 2
DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
125000006165 cyclic alkyl group Chemical group 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
125000001033 ether group Chemical group 0.000 description 2
XKCPMRYMLRYCMI-UHFFFAOYSA-N ethyl 1-[2-(4-chlorophenyl)ethyl]indole-2-carboxylate Chemical compound CCOC(=O)C1=CC2=CC=CC=C2N1CCC1=CC=C(Cl)C=C1 XKCPMRYMLRYCMI-UHFFFAOYSA-N 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
239000011737 fluorine Substances 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 description 2
125000004356 hydroxy functional group Chemical group O* 0.000 description 2
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 2
125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 2
125000000336 imidazol-5-yl group Chemical group [H]N1C([H])=NC([H])=C1[*] 0.000 description 2
SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
KMAKOBLIOCQGJP-UHFFFAOYSA-N indole-3-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CNC2=C1 KMAKOBLIOCQGJP-UHFFFAOYSA-N 0.000 description 2
JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical compound C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 2
230000028709 inflammatory response Effects 0.000 description 2
239000000543 intermediate Substances 0.000 description 2
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
239000004310 lactic acid Substances 0.000 description 2
235000014655 lactic acid Nutrition 0.000 description 2
239000010410 layer Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
NQPIEWBAWBFGOB-UHFFFAOYSA-N methyl 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)OC)=CC2=C1 NQPIEWBAWBFGOB-UHFFFAOYSA-N 0.000 description 2
GLCZQTLCVLVFGV-UHFFFAOYSA-N methyl 4-methoxy-1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)OC)=CC2=C1OC GLCZQTLCVLVFGV-UHFFFAOYSA-N 0.000 description 2
NVOKZHQKGPZQFP-UHFFFAOYSA-N methyl 5-methylsulfonyl-1h-indole-2-carboxylate Chemical compound CS(=O)(=O)C1=CC=C2NC(C(=O)OC)=CC2=C1 NVOKZHQKGPZQFP-UHFFFAOYSA-N 0.000 description 2
239000003094 microcapsule Substances 0.000 description 2
DBNQIOANXZVWIP-UHFFFAOYSA-N n,n-dimethyl-1,1-bis[(2-methylpropan-2-yl)oxy]methanamine Chemical compound CC(C)(C)OC(N(C)C)OC(C)(C)C DBNQIOANXZVWIP-UHFFFAOYSA-N 0.000 description 2
SDKQPEOHLYIXCW-UHFFFAOYSA-N n-[1-(2-aminoacetyl)piperidin-4-yl]-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carboxamide Chemical compound C1CN(C(=O)CN)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 SDKQPEOHLYIXCW-UHFFFAOYSA-N 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
125000001715 oxadiazolyl group Chemical group 0.000 description 2
CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
125000000160 oxazolidinyl group Chemical group 0.000 description 2
FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
125000004193 piperazinyl group Chemical group 0.000 description 2
125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 2
229920005862 polyol Polymers 0.000 description 2
150000003077 polyols Chemical class 0.000 description 2
229910000027 potassium carbonate Inorganic materials 0.000 description 2
229940093956 potassium carbonate Drugs 0.000 description 2
235000011181 potassium carbonates Nutrition 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
WILZYBNDMPNYSV-UHFFFAOYSA-N propan-2-yl 1-[[5-(5-chlorothiophen-2-yl)-1,3,4-thiadiazol-2-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylate Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(=O)OC(C)C)=CC=C2N1CC(S1)=NN=C1C1=CC=C(Cl)S1 WILZYBNDMPNYSV-UHFFFAOYSA-N 0.000 description 2
125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 2
125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 2
125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
238000010992 reflux Methods 0.000 description 2
238000012552 review Methods 0.000 description 2
XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 2
239000003001 serine protease inhibitor Substances 0.000 description 2
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
125000000547 substituted alkyl group Chemical group 0.000 description 2
125000003107 substituted aryl group Chemical group 0.000 description 2
150000003457 sulfones Chemical class 0.000 description 2
238000005694 sulfonylation reaction Methods 0.000 description 2
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
239000000829 suppository Substances 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
KMTMTLIQHPCYTL-UHFFFAOYSA-N tert-butyl 4-(pyridin-4-ylamino)piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NC1=CC=NC=C1 KMTMTLIQHPCYTL-UHFFFAOYSA-N 0.000 description 2
JUOXFFYHDMNFHE-UHFFFAOYSA-N tert-butyl n-(1-ethylpiperidin-4-yl)carbamate Chemical compound CCN1CCC(NC(=O)OC(C)(C)C)CC1 JUOXFFYHDMNFHE-UHFFFAOYSA-N 0.000 description 2
VEXKSFQGMHFQIT-UHFFFAOYSA-N tert-butyl n-(1-pyrimidin-4-ylpiperidin-4-yl)carbamate Chemical compound C1CC(NC(=O)OC(C)(C)C)CCN1C1=CC=NC=N1 VEXKSFQGMHFQIT-UHFFFAOYSA-N 0.000 description 2
DJNCXSGGAMADNN-UHFFFAOYSA-N tert-butyl n-[(4-bromophenyl)methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=C(Br)C=C1 DJNCXSGGAMADNN-UHFFFAOYSA-N 0.000 description 2
RHTXPYGVJVHLQA-UHFFFAOYSA-N tert-butyl n-[(4-pyridin-4-ylphenyl)methyl]carbamate Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1C1=CC=NC=C1 RHTXPYGVJVHLQA-UHFFFAOYSA-N 0.000 description 2
125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
125000004568 thiomorpholinyl group Chemical group 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
125000004417 unsaturated alkyl group Chemical group 0.000 description 2
239000003039 volatile agent Substances 0.000 description 2
XJRIDJAGAYGJCK-UHFFFAOYSA-N (1-acetyl-5-bromoindol-3-yl) acetate Chemical compound C1=C(Br)C=C2C(OC(=O)C)=CN(C(C)=O)C2=C1 XJRIDJAGAYGJCK-UHFFFAOYSA-N 0.000 description 1
BZMMRNKDONDVIB-UHFFFAOYSA-N (1-ethoxycyclopropyl)oxy-trimethylsilane Chemical compound CCOC1(O[Si](C)(C)C)CC1 BZMMRNKDONDVIB-UHFFFAOYSA-N 0.000 description 1
DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
XHTORJWGZKCDGL-GRGSLBFTSA-N (2s)-1-[(2r,3r)-2-amino-3-methylpentanoyl]-n-[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide Chemical compound CC[C@@H](C)[C@@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC1=CC=C([N+]([O-])=O)C=C1 XHTORJWGZKCDGL-GRGSLBFTSA-N 0.000 description 1
DKYRKAIKWFHQHM-UHFFFAOYSA-N (3,5-dichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=CC(Cl)=C1 DKYRKAIKWFHQHM-UHFFFAOYSA-N 0.000 description 1
SDEAGACSNFSZCU-UHFFFAOYSA-N (3-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Cl)=C1 SDEAGACSNFSZCU-UHFFFAOYSA-N 0.000 description 1
XRNVSPDQTPVECU-UHFFFAOYSA-N (4-bromophenyl)methanamine Chemical compound NCC1=CC=C(Br)C=C1 XRNVSPDQTPVECU-UHFFFAOYSA-N 0.000 description 1
CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
UKVYVZLTGQVOPX-IHWYPQMZSA-N (z)-3-aminobut-2-enoic acid Chemical compound C\C(N)=C\C(O)=O UKVYVZLTGQVOPX-IHWYPQMZSA-N 0.000 description 1
RKOUFQLNMRAACI-UHFFFAOYSA-N 1,1,1-trifluoro-2-iodoethane Chemical compound FC(F)(F)CI RKOUFQLNMRAACI-UHFFFAOYSA-N 0.000 description 1
125000004605 1,2,3,4-tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 1
125000004511 1,2,3-thiadiazolyl group Chemical group 0.000 description 1
125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
125000004514 1,2,4-thiadiazolyl group Chemical group 0.000 description 1
125000004517 1,2,5-thiadiazolyl group Chemical group 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 1
125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
ZFLRKAMKGYNFPH-UHFFFAOYSA-N 1,3-dichloro-5-(chloromethyl)benzene Chemical compound ClCC1=CC(Cl)=CC(Cl)=C1 ZFLRKAMKGYNFPH-UHFFFAOYSA-N 0.000 description 1
VAYTZRYEBVHVLE-UHFFFAOYSA-N 1,3-dioxol-2-one Chemical compound O=C1OC=CO1 VAYTZRYEBVHVLE-UHFFFAOYSA-N 0.000 description 1
WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
QDVBKXJMLILLLB-UHFFFAOYSA-N 1,4'-bipiperidine Chemical group C1CCCCN1C1CCNCC1 QDVBKXJMLILLLB-UHFFFAOYSA-N 0.000 description 1
YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
WMKGGPCROCCUDY-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one Chemical compound C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 WMKGGPCROCCUDY-UHFFFAOYSA-N 0.000 description 1
APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
UIVIPMPRAQIEGF-UHFFFAOYSA-N 1-(1h-imidazol-2-ylmethyl)piperidin-4-amine Chemical compound C1CC(N)CCN1CC1=NC=CN1 UIVIPMPRAQIEGF-UHFFFAOYSA-N 0.000 description 1
VCGSBVBNHNWXMC-UHFFFAOYSA-N 1-(3,5-dichlorophenyl)indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1C1=CC(Cl)=CC(Cl)=C1 VCGSBVBNHNWXMC-UHFFFAOYSA-N 0.000 description 1
PPXTYFLXYGZUPJ-UHFFFAOYSA-N 1-(3-chlorophenyl)-n-[(1-propan-2-ylpiperidin-4-yl)methyl]indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1CNC(=O)C1=CC2=CC=CC=C2N1C1=CC=CC(Cl)=C1 PPXTYFLXYGZUPJ-UHFFFAOYSA-N 0.000 description 1
JBIHYTKCJCVSPD-UHFFFAOYSA-N 1-(3-chlorophenyl)-n-[(4-pyridin-4-ylphenyl)methyl]indole-2-carboxamide Chemical compound ClC1=CC=CC(N2C3=CC=CC=C3C=C2C(=O)NCC=2C=CC(=CC=2)C=2C=CN=CC=2)=C1 JBIHYTKCJCVSPD-UHFFFAOYSA-N 0.000 description 1
CRPZABPLZRHXOL-UHFFFAOYSA-N 1-(3-methoxybenzoyl)-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC=CC(C(=O)N2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC2)C(C)C)=C1 CRPZABPLZRHXOL-UHFFFAOYSA-N 0.000 description 1
NLHBHVGPMMXWIM-UHFFFAOYSA-N 1-(4-aminopiperidin-1-yl)ethanone Chemical compound CC(=O)N1CCC(N)CC1 NLHBHVGPMMXWIM-UHFFFAOYSA-N 0.000 description 1
PTTZBUIZEFYPJB-UHFFFAOYSA-N 1-(4-chlorophenyl)-n-[(4-pyridin-4-ylphenyl)methyl]indole-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1N1C2=CC=CC=C2C=C1C(=O)NCC1=CC=C(C=2C=CN=CC=2)C=C1 PTTZBUIZEFYPJB-UHFFFAOYSA-N 0.000 description 1
PURSZYWBIQIANP-UHFFFAOYSA-N 1-(bromomethyl)-2-chlorobenzene Chemical compound ClC1=CC=CC=C1CBr PURSZYWBIQIANP-UHFFFAOYSA-N 0.000 description 1
LZIYAIRGDHSVED-UHFFFAOYSA-N 1-(bromomethyl)-3-chlorobenzene Chemical compound ClC1=CC=CC(CBr)=C1 LZIYAIRGDHSVED-UHFFFAOYSA-N 0.000 description 1
ZKSOJQDNSNJIQW-UHFFFAOYSA-N 1-(bromomethyl)-3-methoxybenzene Chemical compound COC1=CC=CC(CBr)=C1 ZKSOJQDNSNJIQW-UHFFFAOYSA-N 0.000 description 1
CCAWDIFJOBKBSE-UHFFFAOYSA-N 1-(chloromethyl)-3,5-dimethoxybenzene Chemical compound COC1=CC(CCl)=CC(OC)=C1 CCAWDIFJOBKBSE-UHFFFAOYSA-N 0.000 description 1
XZYLSJPLCLKCMR-UHFFFAOYSA-N 1-(pyridin-4-ylmethyl)piperazine Chemical compound C=1C=NC=CC=1CN1CCNCC1 XZYLSJPLCLKCMR-UHFFFAOYSA-N 0.000 description 1
PYKUMPNYIMWHHN-UHFFFAOYSA-N 1-[(1-methylimidazol-2-yl)methyl]piperidin-4-amine Chemical compound CN1C=CN=C1CN1CCC(N)CC1 PYKUMPNYIMWHHN-UHFFFAOYSA-N 0.000 description 1
IZKCMJCLFXTSAA-UHFFFAOYSA-N 1-[(2,4-dichlorophenyl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=CC=C(Cl)C=C1Cl IZKCMJCLFXTSAA-UHFFFAOYSA-N 0.000 description 1
GLYSMLQYMKZMKC-UHFFFAOYSA-N 1-[(3,5-dimethoxyphenyl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound COC1=CC(OC)=CC(CN2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC2)C(C)C)=C1 GLYSMLQYMKZMKC-UHFFFAOYSA-N 0.000 description 1
FXQMOQVEXWRJHX-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=CC=C(Cl)C=C1 FXQMOQVEXWRJHX-UHFFFAOYSA-N 0.000 description 1
ZDQVBRYYEVKIEZ-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1C2=CC=CC=C2C=C1C(=O)NC1CCN(C(C)C)CC1 ZDQVBRYYEVKIEZ-UHFFFAOYSA-N 0.000 description 1
XMBHXMWOQCBVDD-UHFFFAOYSA-N 1-[2-(4-chloroanilino)-2-oxoethyl]-5-nitro-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC([N+]([O-])=O)=CC=C2N1CC(=O)NC1=CC=C(Cl)C=C1 XMBHXMWOQCBVDD-UHFFFAOYSA-N 0.000 description 1
SYYLBTHATZNOSE-UHFFFAOYSA-N 1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]indole-2-carboxylic acid Chemical compound C1=CC=C2N(CC(=O)OC(C)(C)C)C(C(O)=O)=CC2=C1 SYYLBTHATZNOSE-UHFFFAOYSA-N 0.000 description 1
ULFVOACEJNLMDE-UHFFFAOYSA-N 1-[2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl]-5-fluoroindole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC(F)=CC=C2N1CC(=O)NC1=CC=C(Cl)C=N1 ULFVOACEJNLMDE-UHFFFAOYSA-N 0.000 description 1
YEUPDDNYVSLYJV-UHFFFAOYSA-N 1-[[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=CSC(C=2C=CC(Cl)=CC=2)=N1 YEUPDDNYVSLYJV-UHFFFAOYSA-N 0.000 description 1
DPEUKUWEBKRAKG-UHFFFAOYSA-N 1-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC(ON=1)=NC=1C1=CC=C(Cl)C=C1 DPEUKUWEBKRAKG-UHFFFAOYSA-N 0.000 description 1
ROIQWUPGZWRPPT-UHFFFAOYSA-N 1-[[4-(trifluoromethoxy)phenyl]methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC1=CC=C(OC(F)(F)F)C=C1 ROIQWUPGZWRPPT-UHFFFAOYSA-N 0.000 description 1
BDFXRPZVFXZJMA-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-4-carboxylic acid;hydrochloride Chemical compound Cl.C1CN(C(C)C)CCC1NC(=O)C1=CC2=C(C(O)=O)C=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 BDFXRPZVFXZJMA-UHFFFAOYSA-N 0.000 description 1
UJOBUGOPPZARCD-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-3,7-dicyano-4-methoxy-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=C(C#N)C=2C(OC)=CC=C(C#N)C=2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 UJOBUGOPPZARCD-UHFFFAOYSA-N 0.000 description 1
FWLFQJFZPDIYBO-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-3,7-diiodo-4-methoxy-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=C(I)C=2C(OC)=CC=C(I)C=2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 FWLFQJFZPDIYBO-UHFFFAOYSA-N 0.000 description 1
CFBOBFQVPRCOQN-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-3,7-diiodo-4-methoxyindole-2-carboxylic acid Chemical compound OC(=O)C1=C(I)C=2C(OC)=CC=C(I)C=2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 CFBOBFQVPRCOQN-UHFFFAOYSA-N 0.000 description 1
YNGBTQWWOMFMNU-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-3-cyano-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=C(C#N)C2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 YNGBTQWWOMFMNU-UHFFFAOYSA-N 0.000 description 1
KPIQURKZNMPNNM-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-3-fluoro-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=C(F)C2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 KPIQURKZNMPNNM-UHFFFAOYSA-N 0.000 description 1
YPMNISYHHHCQHD-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4,6-dimethoxyindole-2-carboxylic acid Chemical compound C12=CC(OC)=CC(OC)=C2C=C(C(O)=O)N1CC(=NO1)C=C1C1=CC=C(Cl)S1 YPMNISYHHHCQHD-UHFFFAOYSA-N 0.000 description 1
VXSLNADKHRDORH-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4,7-dimethoxyindole-2-carboxylic acid Chemical compound OC(=O)C1=CC=2C(OC)=CC=C(OC)C=2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 VXSLNADKHRDORH-UHFFFAOYSA-N 0.000 description 1
MLPHCDSYKWYISI-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4-methoxycarbonylindole-2-carboxylic acid Chemical compound OC(=O)C1=CC=2C(C(=O)OC)=CC=CC=2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 MLPHCDSYKWYISI-UHFFFAOYSA-N 0.000 description 1
VIZGWWDEQVOMMV-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5,7-dinitro-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 VIZGWWDEQVOMMV-UHFFFAOYSA-N 0.000 description 1
NPNNJZJVTXOACX-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-cyano-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C#N)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 NPNNJZJVTXOACX-UHFFFAOYSA-N 0.000 description 1
UHRXNCPHRYVCHW-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-fluoro-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(F)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 UHRXNCPHRYVCHW-UHFFFAOYSA-N 0.000 description 1
NOQUMOVTWWSJOA-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-methoxycarbonylindole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC(C(=O)OC)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 NOQUMOVTWWSJOA-UHFFFAOYSA-N 0.000 description 1
JEUDEWKUPYSFHQ-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-nitro-n-(1-pyridin-4-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C=2C=CN=CC=2)CCC1NC(=O)C1=CC2=CC([N+](=O)[O-])=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 JEUDEWKUPYSFHQ-UHFFFAOYSA-N 0.000 description 1
SELUINYSIMPNOR-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-nitro-n-pyridin-4-yl-n-(1-pyridin-4-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C=2C=CN=CC=2)CCC1N(C=1C=CN=CC=1)C(=O)C1=CC2=CC([N+](=O)[O-])=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 SELUINYSIMPNOR-UHFFFAOYSA-N 0.000 description 1
BFTIGQYPPHDMJL-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-5-phenylmethoxy-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(OCC=3C=CC=CC=3)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 BFTIGQYPPHDMJL-UHFFFAOYSA-N 0.000 description 1
IBXADCJSROAACD-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-7-methyl-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC(C)=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 IBXADCJSROAACD-UHFFFAOYSA-N 0.000 description 1
DSSBUSBGXAYFEJ-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-methylsulfonylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(S(=O)(=O)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 DSSBUSBGXAYFEJ-UHFFFAOYSA-N 0.000 description 1
NNWDHTFSPUCMQQ-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-pyrimidin-4-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC2)C=2N=CN=CC=2)=NO1 NNWDHTFSPUCMQQ-UHFFFAOYSA-N 0.000 description 1
GJUUXHXBHXTVKN-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(4-methylpiperazin-1-yl)indole-2-carboxamide Chemical compound C1CN(C)CCN1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 GJUUXHXBHXTVKN-UHFFFAOYSA-N 0.000 description 1
RASORPKPULRQAN-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-[(1-pyridin-4-ylpiperidin-4-yl)methyl]indole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NCC2CCN(CC2)C=2C=CN=CC=2)=NO1 RASORPKPULRQAN-UHFFFAOYSA-N 0.000 description 1
WAFXIILUCURMFJ-MRXNPFEDSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-[(3r)-1-ethylpyrrolidin-3-yl]indole-2-carboxamide Chemical compound C1N(CC)CC[C@H]1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 WAFXIILUCURMFJ-MRXNPFEDSA-N 0.000 description 1
LMEGRDCZTKGCFY-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-[1-(1h-imidazol-2-ylmethyl)piperidin-4-yl]indole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC=3NC=CN=3)CC2)=NO1 LMEGRDCZTKGCFY-UHFFFAOYSA-N 0.000 description 1
LXDJGDUZQJAKNT-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]indole-2-carboxamide Chemical compound C1CN(CC(F)(F)F)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 LXDJGDUZQJAKNT-UHFFFAOYSA-N 0.000 description 1
JRJAYUPBVNFANK-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-[1-(2-methylpropyl)piperidin-4-yl]indole-2-carboxamide Chemical compound C1CN(CC(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 JRJAYUPBVNFANK-UHFFFAOYSA-N 0.000 description 1
MOKDUCMEGRBEFL-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-[1-[2-(methylamino)-2-oxoethyl]piperidin-4-yl]indole-2-carboxamide Chemical compound C1CN(CC(=O)NC)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 MOKDUCMEGRBEFL-UHFFFAOYSA-N 0.000 description 1
AYAYHKUTXQHYBS-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-piperazin-1-ylindole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NN2CCNCC2)=NO1 AYAYHKUTXQHYBS-UHFFFAOYSA-N 0.000 description 1
JTZXTKCLAADICV-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-pyridin-4-yl-n-(1-pyridin-4-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)N(C2CCN(CC2)C=2C=CN=CC=2)C=2C=CN=CC=2)=NO1 JTZXTKCLAADICV-UHFFFAOYSA-N 0.000 description 1
GREPHJSRGKVNIG-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,3,4-thiadiazol-2-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC1=NN=C(C=2SC(Cl)=CC=2)S1 GREPHJSRGKVNIG-UHFFFAOYSA-N 0.000 description 1
FCNYARFPVRNARM-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,3,4-thiadiazol-2-yl]methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1CC(S1)=NN=C1C1=CC=C(Cl)S1 FCNYARFPVRNARM-UHFFFAOYSA-N 0.000 description 1
YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 description 1
MICMHFIQSAMEJG-UHFFFAOYSA-N 1-bromopyrrolidine-2,5-dione Chemical compound BrN1C(=O)CCC1=O.BrN1C(=O)CCC1=O MICMHFIQSAMEJG-UHFFFAOYSA-N 0.000 description 1
YVRGKFXJZCTTRB-UHFFFAOYSA-N 1-chloroethyl ethyl carbonate Chemical compound CCOC(=O)OC(C)Cl YVRGKFXJZCTTRB-UHFFFAOYSA-N 0.000 description 1
GZWFMQMAEUUNCC-UHFFFAOYSA-N 1-cyclohexylpiperidin-4-amine Chemical compound C1CC(N)CCN1C1CCCCC1 GZWFMQMAEUUNCC-UHFFFAOYSA-N 0.000 description 1
GJTKAAFWJZWEPS-UHFFFAOYSA-N 1-ethoxycarbonyloxyethyl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylate Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(=O)OC(C)OC(=O)OCC)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 GJTKAAFWJZWEPS-UHFFFAOYSA-N 0.000 description 1
SXXILLXXJZHKNL-UHFFFAOYSA-N 1-ethoxycarbonyloxyethyl 1H-indole-4-carboxylate Chemical compound CCOC(=O)OC(C)OC(=O)C1=CC=CC2=C1C=CN2 SXXILLXXJZHKNL-UHFFFAOYSA-N 0.000 description 1
PRIGFEJKMMRJSF-UHFFFAOYSA-M 1-fluoro-2,4,6-trimethylpyridin-1-ium;trifluoromethanesulfonate Chemical compound [O-]S(=O)(=O)C(F)(F)F.CC1=CC(C)=[N+](F)C(C)=C1 PRIGFEJKMMRJSF-UHFFFAOYSA-M 0.000 description 1
DPJHZJGAGIWXTD-UHFFFAOYSA-N 1-fluoro-4-methylsulfonylbenzene Chemical class CS(=O)(=O)C1=CC=C(F)C=C1 DPJHZJGAGIWXTD-UHFFFAOYSA-N 0.000 description 1
JFZMMCYRTJBQQI-UHFFFAOYSA-M 1-fluoropyridin-1-ium;trifluoromethanesulfonate Chemical compound F[N+]1=CC=CC=C1.[O-]S(=O)(=O)C(F)(F)F JFZMMCYRTJBQQI-UHFFFAOYSA-M 0.000 description 1
UEBFLTZXUXZPJO-UHFFFAOYSA-N 1-methylimidazole-2-carbaldehyde Chemical compound CN1C=CN=C1C=O UEBFLTZXUXZPJO-UHFFFAOYSA-N 0.000 description 1
MAHAMBLNIDMREX-UHFFFAOYSA-N 1-methylindole-2-carboxylic acid Chemical compound C1=CC=C2N(C)C(C(O)=O)=CC2=C1 MAHAMBLNIDMREX-UHFFFAOYSA-N 0.000 description 1
HUJXRKYMGBLFMK-UHFFFAOYSA-N 1-pentan-3-ylpiperidin-4-amine Chemical compound CCC(CC)N1CCC(N)CC1 HUJXRKYMGBLFMK-UHFFFAOYSA-N 0.000 description 1
BWAHBHHABJDRBX-UHFFFAOYSA-N 1-phenylmethoxyindole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC=CC=C2N1OCC1=CC=CC=C1 BWAHBHHABJDRBX-UHFFFAOYSA-N 0.000 description 1
125000006017 1-propenyl group Chemical group 0.000 description 1
125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
MXQDWYDUBAAGAF-UHFFFAOYSA-N 1-pyrimidin-4-ylpiperidin-4-amine;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1CC(N)CCN1C1=CC=NC=N1 MXQDWYDUBAAGAF-UHFFFAOYSA-N 0.000 description 1
125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
MBNROFBGTNXXMX-UHFFFAOYSA-N 1h-indole-2,3-dicarboxylic acid Chemical compound C1=CC=C2C(C(O)=O)=C(C(=O)O)NC2=C1 MBNROFBGTNXXMX-UHFFFAOYSA-N 0.000 description 1
125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
ALODELTWBLGZGB-UHFFFAOYSA-N 2,2-dimethylpropanoyloxymethyl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-5-carboxylate Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC(C(=O)OCOC(=O)C(C)(C)C)=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 ALODELTWBLGZGB-UHFFFAOYSA-N 0.000 description 1
BTTNYQZNBZNDOR-UHFFFAOYSA-N 2,4-dichloropyrimidine Chemical compound ClC1=CC=NC(Cl)=N1 BTTNYQZNBZNDOR-UHFFFAOYSA-N 0.000 description 1
JIJGKPVJAALUQQ-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)ethanol Chemical compound OCCC1=CC=C(Cl)C=C1Cl JIJGKPVJAALUQQ-UHFFFAOYSA-N 0.000 description 1
UPPGEJSCUZMCMW-UHFFFAOYSA-N 2-(3-methoxyphenyl)ethanol Chemical compound COC1=CC=CC(CCO)=C1 UPPGEJSCUZMCMW-UHFFFAOYSA-N 0.000 description 1
JWRVCVWALQWYIJ-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)acetamide Chemical compound NC1CCN(CC(N)=O)CC1 JWRVCVWALQWYIJ-UHFFFAOYSA-N 0.000 description 1
HZFRKZWBVUJYDA-UHFFFAOYSA-N 2-(4-chlorophenyl)ethanol Chemical compound OCCC1=CC=C(Cl)C=C1 HZFRKZWBVUJYDA-UHFFFAOYSA-N 0.000 description 1
OIWKPVLNEDEDPC-UHFFFAOYSA-N 2-(4-chlorophenyl)ethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCC1=CC=C(Cl)C=C1 OIWKPVLNEDEDPC-UHFFFAOYSA-N 0.000 description 1
ITNVXASBWCQERP-UHFFFAOYSA-N 2-(bromomethyl)-5-(5-chlorothiophen-2-yl)-1,3,4-thiadiazole Chemical compound S1C(Cl)=CC=C1C1=NN=C(CBr)S1 ITNVXASBWCQERP-UHFFFAOYSA-N 0.000 description 1
BBTKFFLJVORJDU-UHFFFAOYSA-N 2-(bromomethyl)-6-chloro-1-benzothiophene Chemical compound ClC1=CC=C2C=C(CBr)SC2=C1 BBTKFFLJVORJDU-UHFFFAOYSA-N 0.000 description 1
IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
JXUJGGXPOQRECQ-UHFFFAOYSA-N 2-[2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indol-1-yl]acetic acid Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1CC(O)=O JXUJGGXPOQRECQ-UHFFFAOYSA-N 0.000 description 1
YLYPIBBGWLKELC-RMKNXTFCSA-N 2-[2-[(e)-2-[4-(dimethylamino)phenyl]ethenyl]-6-methylpyran-4-ylidene]propanedinitrile Chemical compound C1=CC(N(C)C)=CC=C1\C=C\C1=CC(=C(C#N)C#N)C=C(C)O1 YLYPIBBGWLKELC-RMKNXTFCSA-N 0.000 description 1
KHMNCHDUSFCTGK-UHFFFAOYSA-N 2-aminophenylacetic acid Chemical class NC1=CC=CC=C1CC(O)=O KHMNCHDUSFCTGK-UHFFFAOYSA-N 0.000 description 1
LSTRKXWIZZZYAS-UHFFFAOYSA-N 2-bromoacetyl bromide Chemical compound BrCC(Br)=O LSTRKXWIZZZYAS-UHFFFAOYSA-N 0.000 description 1
LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
HOZLOOPIXHWKCI-UHFFFAOYSA-N 2-chloro-n-methylacetamide Chemical compound CNC(=O)CCl HOZLOOPIXHWKCI-UHFFFAOYSA-N 0.000 description 1
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
125000006029 2-methyl-2-butenyl group Chemical group 0.000 description 1
125000005916 2-methylpentyl group Chemical group 0.000 description 1
PLAZTCDQAHEYBI-UHFFFAOYSA-N 2-nitrotoluene Chemical class CC1=CC=CC=C1[N+]([O-])=O PLAZTCDQAHEYBI-UHFFFAOYSA-N 0.000 description 1
RNQMFHCNUFEVSQ-UHFFFAOYSA-N 2-o-tert-butyl 5-o-methyl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2,5-dicarboxylate Chemical compound CC(C)(C)OC(=O)C1=CC2=CC(C(=O)OC)=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 RNQMFHCNUFEVSQ-UHFFFAOYSA-N 0.000 description 1
VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical compound C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 description 1
RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
YZBIEKKAKFEWIL-UHFFFAOYSA-N 3-(2-carboxyethyl)-6-chloro-1h-indole-2-carboxylic acid Chemical compound ClC1=CC=C2C(CCC(=O)O)=C(C(O)=O)NC2=C1 YZBIEKKAKFEWIL-UHFFFAOYSA-N 0.000 description 1
KQSJKIFUOUFTQO-UHFFFAOYSA-N 3-(2-ethoxy-2-oxoethyl)-1h-indole-2-carboxylic acid Chemical compound C1=CC=C2C(CC(=O)OCC)=C(C(O)=O)NC2=C1 KQSJKIFUOUFTQO-UHFFFAOYSA-N 0.000 description 1
ORRDZVRYRNYLMB-UHFFFAOYSA-N 3-(bromomethyl)benzamide Chemical compound NC(=O)C1=CC=CC(CBr)=C1 ORRDZVRYRNYLMB-UHFFFAOYSA-N 0.000 description 1
JKSRJLOJDZYJLA-UHFFFAOYSA-N 3-(chloromethyl)-5-(4-chlorophenyl)-1,2-oxazole Chemical compound O1N=C(CCl)C=C1C1=CC=C(Cl)C=C1 JKSRJLOJDZYJLA-UHFFFAOYSA-N 0.000 description 1
YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
TZEVLCOAJTZLBW-UHFFFAOYSA-N 3-[[2-[4-(propan-2-ylamino)piperidine-1-carbonyl]indol-1-yl]methyl]benzamide Chemical compound C1CC(NC(C)C)CCN1C(=O)C1=CC2=CC=CC=C2N1CC1=CC=CC(C(N)=O)=C1 TZEVLCOAJTZLBW-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
UKOOKNYBHMFHHH-UHFFFAOYSA-N 3-bromo-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=C(Br)C2=CC=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 UKOOKNYBHMFHHH-UHFFFAOYSA-N 0.000 description 1
125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
BNZKBEYBBUIEME-UHFFFAOYSA-N 3-chloro-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=C(Cl)C2=CC=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 BNZKBEYBBUIEME-UHFFFAOYSA-N 0.000 description 1
JHJKSEKUZNJKGO-UHFFFAOYSA-N 3-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=CC(S(Cl)(=O)=O)=C1 JHJKSEKUZNJKGO-UHFFFAOYSA-N 0.000 description 1
125000005917 3-methylpentyl group Chemical group 0.000 description 1
GSODHWYZNHBOHR-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1h-diazepine Chemical compound C1CCC=NNC1 GSODHWYZNHBOHR-UHFFFAOYSA-N 0.000 description 1
DHXISZKSSIWRLH-UHFFFAOYSA-N 4,6-dichloro-1h-indole-2-carboxylic acid Chemical compound C1=C(Cl)C=C2NC(C(=O)O)=CC2=C1Cl DHXISZKSSIWRLH-UHFFFAOYSA-N 0.000 description 1
BBNNLOXOBPZQGU-UHFFFAOYSA-N 4,7-dichloro-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-n-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=C(Cl)C=CC(Cl)=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 BBNNLOXOBPZQGU-UHFFFAOYSA-N 0.000 description 1
FJWNGDWJFIQNEG-UHFFFAOYSA-N 4,7-dimethoxy-1h-indole-2-carboxylic acid Chemical compound COC1=CC=C(OC)C2=C1C=C(C(O)=O)N2 FJWNGDWJFIQNEG-UHFFFAOYSA-N 0.000 description 1
DXGLNXJHHJNUHD-UHFFFAOYSA-N 4,7-dimethyl-1h-indole-2-carboxylic acid Chemical compound CC1=CC=C(C)C2=C1C=C(C(O)=O)N2 DXGLNXJHHJNUHD-UHFFFAOYSA-N 0.000 description 1
UEJQTBKTWJQBRN-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-chlorophenyl)-1,3-thiazole Chemical compound ClCC1=CSC(C=2C=CC(Cl)=CC=2)=N1 UEJQTBKTWJQBRN-UHFFFAOYSA-N 0.000 description 1
MOVKDRSEEJWXRI-UHFFFAOYSA-N 4-(trifluoromethyl)-1h-indole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC2=C1C(F)(F)F MOVKDRSEEJWXRI-UHFFFAOYSA-N 0.000 description 1
VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
XQSPYNMVSIKCOC-RITPCOANSA-N 4-amino-5-fluoro-1-[(2s,5r)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one Chemical compound C1=C(F)C(N)=NC(=O)N1[C@@H]1O[C@H](CO)SC1 XQSPYNMVSIKCOC-RITPCOANSA-N 0.000 description 1
GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 description 1
125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
RYHLFGOYQFFDAG-UHFFFAOYSA-N 4-methoxy-1-[(3-methoxyphenyl)methyl]indole-2-carboxylic acid Chemical compound COC1=CC=CC(CN2C3=CC=CC(OC)=C3C=C2C(O)=O)=C1 RYHLFGOYQFFDAG-UHFFFAOYSA-N 0.000 description 1
QMSCXKCJGFIXDF-UHFFFAOYSA-N 4-methyl-1h-indole-2-carboxylic acid Chemical compound CC1=CC=CC2=C1C=C(C(O)=O)N2 QMSCXKCJGFIXDF-UHFFFAOYSA-N 0.000 description 1
GKVYVZSNXXTOMQ-UHFFFAOYSA-N 4-pyridin-4-ylaniline Chemical compound C1=CC(N)=CC=C1C1=CC=NC=C1 GKVYVZSNXXTOMQ-UHFFFAOYSA-N 0.000 description 1
WRDWWAVNELMWAM-UHFFFAOYSA-N 4-tert-butylaniline Chemical compound CC(C)(C)C1=CC=C(N)C=C1 WRDWWAVNELMWAM-UHFFFAOYSA-N 0.000 description 1
YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
QILAXMNESNFYJG-UHFFFAOYSA-N 5,7-dichloro-1h-indole-2-carboxylic acid Chemical compound ClC1=CC(Cl)=C2NC(C(=O)O)=CC2=C1 QILAXMNESNFYJG-UHFFFAOYSA-N 0.000 description 1
NSPBTJFAUPZOHK-UHFFFAOYSA-N 5-(chloromethyl)-3-(4-chlorophenyl)-1,2-oxazole Chemical compound O1C(CCl)=CC(C=2C=CC(Cl)=CC=2)=N1 NSPBTJFAUPZOHK-UHFFFAOYSA-N 0.000 description 1
125000004539 5-benzimidazolyl group Chemical group N1=CNC2=C1C=CC(=C2)* 0.000 description 1
LFDIYOCTFJLROW-UHFFFAOYSA-N 5-chloro-1-[2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl]indole-2-carboxylic acid Chemical compound OC(=O)C1=CC2=CC(Cl)=CC=C2N1CC(=O)NC1=CC=C(Cl)C=N1 LFDIYOCTFJLROW-UHFFFAOYSA-N 0.000 description 1
FUQOTYRCMBZFOL-UHFFFAOYSA-N 5-chloro-1H-indole-2-carboxylic acid Chemical compound ClC1=CC=C2NC(C(=O)O)=CC2=C1 FUQOTYRCMBZFOL-UHFFFAOYSA-N 0.000 description 1
PCHBMNCFKJKQPA-UHFFFAOYSA-N 5-chlorothiophen-2-amine Chemical compound NC1=CC=C(Cl)S1 PCHBMNCFKJKQPA-UHFFFAOYSA-N 0.000 description 1
AXAUNIVIEFHPSY-UHFFFAOYSA-N 5-cyano-1h-indole-2-carboxylic acid Chemical compound N#CC1=CC=C2NC(C(=O)O)=CC2=C1 AXAUNIVIEFHPSY-UHFFFAOYSA-N 0.000 description 1
WTXBRZCVLDTWLP-UHFFFAOYSA-N 5-fluoro-1H-indole-2-carboxylic acid Chemical compound FC1=CC=C2NC(C(=O)O)=CC2=C1 WTXBRZCVLDTWLP-UHFFFAOYSA-N 0.000 description 1
125000006043 5-hexenyl group Chemical group 0.000 description 1
DAITVOCMWPNFTL-UHFFFAOYSA-N 5-methyl-1h-indole-2-carboxylic acid Chemical compound CC1=CC=C2NC(C(O)=O)=CC2=C1 DAITVOCMWPNFTL-UHFFFAOYSA-N 0.000 description 1
NVKJOXRVEKMMHS-UHFFFAOYSA-N 5-nitro-1,2,4-triazol-3-one Chemical compound [O-][N+](=O)C1=NC(=O)N=N1 NVKJOXRVEKMMHS-UHFFFAOYSA-N 0.000 description 1
MVCLSAMNMAWXFQ-UHFFFAOYSA-N 5-phenylmethoxy-1h-indole-2-carboxylic acid Chemical compound C=1C=C2NC(C(=O)O)=CC2=CC=1OCC1=CC=CC=C1 MVCLSAMNMAWXFQ-UHFFFAOYSA-N 0.000 description 1
HPTPAOBHDQIIAO-UHFFFAOYSA-N 5-propan-2-yloxycarbonyl-1h-indole-2-carboxylic acid Chemical compound CC(C)OC(=O)C1=CC=C2NC(C(O)=O)=CC2=C1 HPTPAOBHDQIIAO-UHFFFAOYSA-N 0.000 description 1
125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 description 1
OFKCWDHRSIVZST-UHFFFAOYSA-N 7-(2,2-dimethylpropanoylamino)-1h-indole-2-carboxylic acid Chemical compound CC(C)(C)C(=O)NC1=CC=CC2=C1NC(C(O)=O)=C2 OFKCWDHRSIVZST-UHFFFAOYSA-N 0.000 description 1
UJHWOZFZLVVMIX-UHFFFAOYSA-N 7-[(4-methoxyphenyl)sulfonylamino]-1h-indole-2-carboxylic acid Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NC1=CC=CC2=C1NC(C(O)=O)=C2 UJHWOZFZLVVMIX-UHFFFAOYSA-N 0.000 description 1
ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
PJAPZFQNRZEBQJ-UHFFFAOYSA-N C1=CC2=C(C(=C1)Cl)C(=C(N2CC3=NOC(=C3)C4=CC=C(S4)Cl)C(=O)O)Cl Chemical compound C1=CC2=C(C(=C1)Cl)C(=C(N2CC3=NOC(=C3)C4=CC=C(S4)Cl)C(=O)O)Cl PJAPZFQNRZEBQJ-UHFFFAOYSA-N 0.000 description 1
GEAXQZLZUYQYKZ-UHFFFAOYSA-N CC(C)N(CC1)CCC1N.OC(C1=CC2=CC=CC=C2N1CC(C=C1)=CC=C1Cl)=O Chemical compound CC(C)N(CC1)CCC1N.OC(C1=CC2=CC=CC=C2N1CC(C=C1)=CC=C1Cl)=O GEAXQZLZUYQYKZ-UHFFFAOYSA-N 0.000 description 1
FFYHAEWYPZXPMZ-UHFFFAOYSA-N COC(=O)C1=C(C2=CC=CC=C2N1F)F Chemical compound COC(=O)C1=C(C2=CC=CC=C2N1F)F FFYHAEWYPZXPMZ-UHFFFAOYSA-N 0.000 description 1
GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
DYHSDKLCOJIUFX-UHFFFAOYSA-N Di-tert-butyl dicarbonate Substances CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
108010088842 Fibrinolysin Proteins 0.000 description 1
238000006783 Fischer indole synthesis reaction Methods 0.000 description 1
238000006641 Fischer synthesis reaction Methods 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000007821 HATU Substances 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
238000005684 Liebig rearrangement reaction Methods 0.000 description 1
238000006861 Madelung synthesis reaction Methods 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
239000012359 Methanesulfonyl chloride Substances 0.000 description 1
MRLVFVTVXSKAMX-UHFFFAOYSA-N Methyl 4-amino-3-iodobenzoate Chemical compound COC(=O)C1=CC=C(N)C(I)=C1 MRLVFVTVXSKAMX-UHFFFAOYSA-N 0.000 description 1
FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
230000006181 N-acylation Effects 0.000 description 1
241001181114 Neta Species 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
241000282520 Papio Species 0.000 description 1
BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
108010022999 Serine Proteases Proteins 0.000 description 1
102000012479 Serine Proteases Human genes 0.000 description 1
241000610375 Sparisoma viride Species 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
229940122388 Thrombin inhibitor Drugs 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
206010047249 Venous thrombosis Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
BBAWTPDTGRXPDG-UHFFFAOYSA-N [1,3]thiazolo[4,5-b]pyridine Chemical compound C1=CC=C2SC=NC2=N1 BBAWTPDTGRXPDG-UHFFFAOYSA-N 0.000 description 1
QNVOZUCNAYMYBK-UHFFFAOYSA-N [1-[(3,5-dichlorophenyl)methyl]indol-2-yl]-[4-(propan-2-ylamino)piperidin-1-yl]methanone Chemical compound C1CC(NC(C)C)CCN1C(=O)C1=CC2=CC=CC=C2N1CC1=CC(Cl)=CC(Cl)=C1 QNVOZUCNAYMYBK-UHFFFAOYSA-N 0.000 description 1
QVNWILFMZUQREO-UHFFFAOYSA-N [1-[(3,5-dimethoxyphenyl)methyl]indol-2-yl]-[4-(propan-2-ylamino)piperidin-1-yl]methanone Chemical compound COC1=CC(OC)=CC(CN2C3=CC=CC=C3C=C2C(=O)N2CCC(CC2)NC(C)C)=C1 QVNWILFMZUQREO-UHFFFAOYSA-N 0.000 description 1
MGMRQNKJMRCNMF-UHFFFAOYSA-N [1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indol-2-yl]-[4-(pyridin-4-ylamino)piperidin-1-yl]methanone Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)N2CCC(CC2)NC=2C=CN=CC=2)=NO1 MGMRQNKJMRCNMF-UHFFFAOYSA-N 0.000 description 1
AGURQGJPANOJHX-UHFFFAOYSA-N [5-(aminomethyl)-4,5-dihydro-1,2-oxazol-3-yl]-pyrrolidin-1-ylmethanone Chemical compound O1C(CN)CC(C(=O)N2CCCC2)=N1 AGURQGJPANOJHX-UHFFFAOYSA-N 0.000 description 1
125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
238000007171 acid catalysis Methods 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
239000000654 additive Substances 0.000 description 1
238000012382 advanced drug delivery Methods 0.000 description 1
239000003513 alkali Substances 0.000 description 1
150000001345 alkine derivatives Chemical class 0.000 description 1
125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
125000000304 alkynyl group Chemical group 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
238000010640 amide synthesis reaction Methods 0.000 description 1
125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
229940127090 anticoagulant agent Drugs 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
125000003710 aryl alkyl group Chemical group 0.000 description 1
150000001499 aryl bromides Chemical class 0.000 description 1
150000001501 aryl fluorides Chemical class 0.000 description 1
ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
125000004931 azocinyl group Chemical group N1=C(C=CC=CC=C1)* 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 1
IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
125000005512 benztetrazolyl group Chemical group 0.000 description 1
GBVAGZMJJSANDQ-UHFFFAOYSA-N benzyl 1h-indole-2-carboxylate Chemical compound C=1C2=CC=CC=C2NC=1C(=O)OCC1=CC=CC=C1 GBVAGZMJJSANDQ-UHFFFAOYSA-N 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
229960004217 benzyl alcohol Drugs 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
230000037396 body weight Effects 0.000 description 1
230000031709 bromination Effects 0.000 description 1
238000005893 bromination reaction Methods 0.000 description 1
244000309464 bull Species 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
125000004623 carbolinyl group Chemical group 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
229910002091 carbon monoxide Inorganic materials 0.000 description 1
229940105305 carbon monoxide Drugs 0.000 description 1
150000001728 carbonyl compounds Chemical class 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
150000001733 carboxylic acid esters Chemical class 0.000 description 1
238000005341 cation exchange Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
238000005660 chlorination reaction Methods 0.000 description 1
FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 1
239000003593 chromogenic compound Substances 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
150000001879 copper Chemical class 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
229940099112 cornstarch Drugs 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000006880 cross-coupling reaction Methods 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
PYRZPBDTPRQYKG-UHFFFAOYSA-N cyclopentene-1-carboxylic acid Chemical compound OC(=O)C1=CCCC1 PYRZPBDTPRQYKG-UHFFFAOYSA-N 0.000 description 1
125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
230000006378 damage Effects 0.000 description 1
DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
238000013461 design Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
239000012954 diazonium Substances 0.000 description 1
IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
229940117389 dichlorobenzene Drugs 0.000 description 1
229960004132 diethyl ether Drugs 0.000 description 1
238000007865 diluting Methods 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 1
IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
239000012039 electrophile Substances 0.000 description 1
238000007345 electrophilic aromatic substitution reaction Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
229940052303 ethers for general anesthesia Drugs 0.000 description 1
125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
BLWZGFPNCAEYMO-UHFFFAOYSA-N ethyl 1-[2-(4-chloroanilino)-2-oxoethyl]indole-2-carboxylate Chemical compound CCOC(=O)C1=CC2=CC=CC=C2N1CC(=O)NC1=CC=C(Cl)C=C1 BLWZGFPNCAEYMO-UHFFFAOYSA-N 0.000 description 1
DVFJMQCNICEPAI-UHFFFAOYSA-N ethyl 5-nitro-1h-indole-2-carboxylate Chemical compound [O-][N+](=O)C1=CC=C2NC(C(=O)OCC)=CC2=C1 DVFJMQCNICEPAI-UHFFFAOYSA-N 0.000 description 1
PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
239000003925 fat Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000003682 fluorination reaction Methods 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000012634 fragment Substances 0.000 description 1
125000003838 furazanyl group Chemical group 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000002140 halogenating effect Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
150000004678 hydrides Chemical class 0.000 description 1
229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
KRGRHIQRVYJCIG-UHFFFAOYSA-N hydron;1-propan-2-ylpiperidin-4-amine;dichloride Chemical compound Cl.Cl.CC(C)N1CCC(N)CC1 KRGRHIQRVYJCIG-UHFFFAOYSA-N 0.000 description 1
125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 1
125000002632 imidazolidinyl group Chemical group 0.000 description 1
MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
125000002636 imidazolinyl group Chemical group 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
125000000593 indol-1-yl group Chemical group [H]C1=C([H])C([H])=C2N([*])C([H])=C([H])C2=C1[H] 0.000 description 1
125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 description 1
239000003617 indole-3-acetic acid Substances 0.000 description 1
125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
239000003978 infusion fluid Substances 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229960004903 invert sugar Drugs 0.000 description 1
238000011835 investigation Methods 0.000 description 1
230000026045 iodination Effects 0.000 description 1
238000006192 iodination reaction Methods 0.000 description 1
MGFYSGNNHQQTJW-UHFFFAOYSA-N iodonium Chemical compound [IH2+] MGFYSGNNHQQTJW-UHFFFAOYSA-N 0.000 description 1
125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
125000005438 isoindazolyl group Chemical group 0.000 description 1
GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
108010075079 isoleucyl-prolyl-arginine-4-nitroanilide Proteins 0.000 description 1
125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
125000004551 isoquinolin-3-yl group Chemical group C1=NC(=CC2=CC=CC=C12)* 0.000 description 1
125000004552 isoquinolin-4-yl group Chemical group C1=NC=C(C2=CC=CC=C12)* 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
238000003367 kinetic assay Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000006138 lithiation reaction Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
125000005905 mesyloxy group Chemical group 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 1
CGVAQVAXTQEDNM-UHFFFAOYSA-N methyl 1-(4-methoxyphenyl)indole-2-carboxylate Chemical compound COC(=O)C1=CC2=CC=CC=C2N1C1=CC=C(OC)C=C1 CGVAQVAXTQEDNM-UHFFFAOYSA-N 0.000 description 1
XXEVPROBSOHXIT-UHFFFAOYSA-N methyl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-2-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]indole-4-carboxylate Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC=2C(C(=O)OC)=CC=CC=2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 XXEVPROBSOHXIT-UHFFFAOYSA-N 0.000 description 1
UJYLZXNTRAEJBB-UHFFFAOYSA-N methyl 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carboxylate Chemical compound COC(=O)C1=CC2=CC=CC=C2N1CC(=NO1)C=C1C1=CC=C(Cl)S1 UJYLZXNTRAEJBB-UHFFFAOYSA-N 0.000 description 1
PEHJJMYCHVPFCG-UHFFFAOYSA-N methyl 1-methylindole-2-carboxylate Chemical compound C1=CC=C2N(C)C(C(=O)OC)=CC2=C1 PEHJJMYCHVPFCG-UHFFFAOYSA-N 0.000 description 1
DRYBMFJLYYEOBZ-UHFFFAOYSA-N methyl 1h-indole-5-carboxylate Chemical compound COC(=O)C1=CC=C2NC=CC2=C1 DRYBMFJLYYEOBZ-UHFFFAOYSA-N 0.000 description 1
HRGIGMGNLJTQEQ-UHFFFAOYSA-N methyl 3-cyano-1h-indole-2-carboxylate Chemical compound C1=CC=C2C(C#N)=C(C(=O)OC)NC2=C1 HRGIGMGNLJTQEQ-UHFFFAOYSA-N 0.000 description 1
AXJGVTDNUULIKN-UHFFFAOYSA-N methyl 4,4,5,5,6,6,7,7-octafluoro-3-oxoheptanoate Chemical compound COC(=O)CC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)F AXJGVTDNUULIKN-UHFFFAOYSA-N 0.000 description 1
WGAOEHZSJWVLBY-UHFFFAOYSA-N methyl 5-chloro-1h-indole-2-carboxylate Chemical compound ClC1=CC=C2NC(C(=O)OC)=CC2=C1 WGAOEHZSJWVLBY-UHFFFAOYSA-N 0.000 description 1
QUZGGDBUGGJROM-UHFFFAOYSA-N methyl 5-fluoro-1h-indole-2-carboxylate Chemical compound FC1=CC=C2NC(C(=O)OC)=CC2=C1 QUZGGDBUGGJROM-UHFFFAOYSA-N 0.000 description 1
XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
YGZYVBHJLLVOKE-UHFFFAOYSA-N n-(1-propan-2-ylpiperidin-4-yl)-1h-indole-2-carboxamide Chemical compound C1CN(C(C)C)CCC1NC(=O)C1=CC2=CC=CC=C2N1 YGZYVBHJLLVOKE-UHFFFAOYSA-N 0.000 description 1
ABRZLNLFABKMCJ-UHFFFAOYSA-N n-(1-pyridin-4-ylpiperidin-4-yl)pyridin-4-amine Chemical compound C1CN(C=2C=CN=CC=2)CCC1NC1=CC=NC=C1 ABRZLNLFABKMCJ-UHFFFAOYSA-N 0.000 description 1
WHVRIEBTPHOXEE-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[2-(4-pyrrolidin-1-ylpiperidine-1-carbonyl)indol-1-yl]acetamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)CN1C2=CC=CC=C2C=C1C(=O)N1CCC(N2CCCC2)CC1 WHVRIEBTPHOXEE-UHFFFAOYSA-N 0.000 description 1
CJWRWSIZDGWSLT-UHFFFAOYSA-N n-(4-iodophenyl)-1-[(3-methoxyphenyl)methyl]indole-2-carboxamide Chemical compound COC1=CC=CC(CN2C3=CC=CC=C3C=C2C(=O)NC=2C=CC(I)=CC=2)=C1 CJWRWSIZDGWSLT-UHFFFAOYSA-N 0.000 description 1
YSCLDBIQLDEDMZ-UHFFFAOYSA-N n-[1-(2-chloropyrimidin-4-yl)piperidin-4-yl]-1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carboxamide Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C3=CC=CC=C3C=C2C(=O)NC2CCN(CC2)C=2N=C(Cl)N=CC=2)=NO1 YSCLDBIQLDEDMZ-UHFFFAOYSA-N 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
VSHTWPWTCXQLQN-UHFFFAOYSA-N n-butylaniline Chemical compound CCCCNC1=CC=CC=C1 VSHTWPWTCXQLQN-UHFFFAOYSA-N 0.000 description 1
KUDPGZONDFORKU-UHFFFAOYSA-N n-chloroaniline Chemical class ClNC1=CC=CC=C1 KUDPGZONDFORKU-UHFFFAOYSA-N 0.000 description 1
NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
TVWJOMGXJWDIQA-UHFFFAOYSA-N n-methyl-1-pyridin-4-ylpiperidin-4-amine Chemical compound C1CC(NC)CCN1C1=CC=NC=C1 TVWJOMGXJWDIQA-UHFFFAOYSA-N 0.000 description 1
SESXBIFUTWZZOU-UHFFFAOYSA-N n-piperidin-4-ylpyridin-4-amine Chemical compound C1CNCCC1NC1=CC=NC=C1 SESXBIFUTWZZOU-UHFFFAOYSA-N 0.000 description 1
GINABUAPACIWCA-UHFFFAOYSA-N n-propan-2-ylpiperidin-4-amine Chemical compound CC(C)NC1CCNCC1 GINABUAPACIWCA-UHFFFAOYSA-N 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
125000004930 octahydroisoquinolinyl group Chemical group C1(NCCC2CCCC=C12)* 0.000 description 1
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
150000003901 oxalic acid esters Chemical class 0.000 description 1
JMJRYTGVHCAYCT-UHFFFAOYSA-N oxan-4-one Chemical compound O=C1CCOCC1 JMJRYTGVHCAYCT-UHFFFAOYSA-N 0.000 description 1
YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
125000005954 phenoxathiinyl group Chemical group 0.000 description 1
125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl chloride Substances ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
IYPZRUYMFDWKSS-UHFFFAOYSA-N piperazin-1-amine Chemical compound NN1CCNCC1 IYPZRUYMFDWKSS-UHFFFAOYSA-N 0.000 description 1
125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
125000004574 piperidin-2-yl group Chemical group N1C(CCCC1)* 0.000 description 1
JLPGSSHHLKZYMJ-UHFFFAOYSA-N piperidin-4-amine;hydrochloride Chemical compound Cl.NC1CCNCC1 JLPGSSHHLKZYMJ-UHFFFAOYSA-N 0.000 description 1
KBOGICFUPOMDKS-UHFFFAOYSA-N piperidin-4-ylcarbamic acid Chemical compound OC(=O)NC1CCNCC1 KBOGICFUPOMDKS-UHFFFAOYSA-N 0.000 description 1
229940012957 plasmin Drugs 0.000 description 1
229920005990 polystyrene resin Polymers 0.000 description 1
LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
238000011533 pre-incubation Methods 0.000 description 1
125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
JGDTVBLOYMDZNS-UHFFFAOYSA-N propan-2-yl 1h-indole-5-carboxylate Chemical compound CC(C)OC(=O)C1=CC=C2NC=CC2=C1 JGDTVBLOYMDZNS-UHFFFAOYSA-N 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
108010014806 prothrombinase complex Proteins 0.000 description 1
125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
IWRRRCZSVINKHU-UHFFFAOYSA-N pyrazol-3-ylidenemethanone Chemical class O=C=C1C=CN=N1 IWRRRCZSVINKHU-UHFFFAOYSA-N 0.000 description 1
125000002755 pyrazolinyl group Chemical group 0.000 description 1
QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 1
125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 description 1
ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
125000001422 pyrrolinyl group Chemical group 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
125000004159 quinolin-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C([H])C(*)=NC2=C1[H] 0.000 description 1
125000004548 quinolin-3-yl group Chemical group N1=CC(=CC2=CC=CC=C12)* 0.000 description 1
125000004549 quinolin-4-yl group Chemical group N1=CC=C(C2=CC=CC=C12)* 0.000 description 1
125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
238000011160 research Methods 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 1
DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
208000013223 septicemia Diseases 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
239000012265 solid product Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
230000000707 stereoselective effect Effects 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
150000003460 sulfonic acids Chemical class 0.000 description 1
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
230000006103 sulfonylation Effects 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
125000004434 sulfur atom Chemical group 0.000 description 1
238000006557 surface reaction Methods 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
OMRJWYAXNHIRDD-UHFFFAOYSA-N tert-butyl 4-[[1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]indole-2-carbonyl]amino]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1NC(=O)C1=CC2=CC=CC=C2N1CC1=NOC(C=2SC(Cl)=CC=2)=C1 OMRJWYAXNHIRDD-UHFFFAOYSA-N 0.000 description 1
QMZFIRHRGPLKEV-UHFFFAOYSA-N tert-butyl 4-aminopiperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(N)CC1 QMZFIRHRGPLKEV-UHFFFAOYSA-N 0.000 description 1
LZRDHSFPLUWYAX-UHFFFAOYSA-N tert-butyl 4-aminopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(N)CC1 LZRDHSFPLUWYAX-UHFFFAOYSA-N 0.000 description 1
ORDWBNAADSSUPV-UHFFFAOYSA-N tert-butyl 4-bromo-1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)OC(C)(C)C)=CC2=C1Br ORDWBNAADSSUPV-UHFFFAOYSA-N 0.000 description 1
QHPWESLNMUXZMX-UHFFFAOYSA-N tert-butyl n-(1-cyclopropylpiperidin-4-yl)carbamate Chemical compound C1CC(NC(=O)OC(C)(C)C)CCN1C1CC1 QHPWESLNMUXZMX-UHFFFAOYSA-N 0.000 description 1
AUFRDMQSECOCAZ-UHFFFAOYSA-N tert-butyl n-(1-pyridin-4-ylpiperidin-4-yl)carbamate Chemical compound C1CC(NC(=O)OC(C)(C)C)CCN1C1=CC=NC=C1 AUFRDMQSECOCAZ-UHFFFAOYSA-N 0.000 description 1
VHYXAWLOJGIJPC-UHFFFAOYSA-N tert-butyl n-(piperidin-4-ylmethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCC1CCNCC1 VHYXAWLOJGIJPC-UHFFFAOYSA-N 0.000 description 1
238000012360 testing method Methods 0.000 description 1
UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 1
WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 1
CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical compound C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
150000007970 thio esters Chemical class 0.000 description 1
239000003868 thrombin inhibitor Substances 0.000 description 1
230000001732 thrombotic effect Effects 0.000 description 1
HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
229960001322 trypsin Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
239000001993 wax Substances 0.000 description 1
238000005303 weighing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
238000010626 work up procedure Methods 0.000 description 1
125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Ceramic Engineering (AREA)
Manufacturing & Machinery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Structural Engineering (AREA)
Materials Engineering (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

OA1200400142A 2001-11-22 2002-11-08 Indole-2-carboxamides as factor XA inhibitors. OA12727A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01127809A EP1314733A1 (en)	2001-11-22	2001-11-22	Indole-2-carboxamides as factor Xa inhibitors

Publications (1)

Publication Number	Publication Date
OA12727A true OA12727A (en)	2006-06-27

Family

ID=8179313

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA1200400142A OA12727A (en)	2001-11-22	2002-11-08	Indole-2-carboxamides as factor XA inhibitors.

Country Status (30)

Country	Link
US (3)	US6906084B2 (sr)
EP (2)	EP1314733A1 (sr)
JP (1)	JP4664592B2 (sr)
KR (2)	KR100954508B1 (sr)
CN (1)	CN1283638C (sr)
AR (1)	AR037656A1 (sr)
AU (1)	AU2002351918B2 (sr)
BR (1)	BR0214396A (sr)
CA (1)	CA2467374C (sr)
CO (1)	CO5580764A2 (sr)
EC (1)	ECSP045115A (sr)
HR (1)	HRP20040453A2 (sr)
HU (1)	HUP0402063A3 (sr)
IL (2)	IL162105A0 (sr)
MA (1)	MA27350A1 (sr)
ME (1)	MEP43008A (sr)
MX (1)	MXPA04004797A (sr)
MY (1)	MY131516A (sr)
NO (1)	NO327466B1 (sr)
NZ (1)	NZ533044A (sr)
OA (1)	OA12727A (sr)
PE (1)	PE20030593A1 (sr)
PL (1)	PL210986B1 (sr)
RS (1)	RS40404A (sr)
RU (1)	RU2299881C2 (sr)
TN (1)	TNSN04091A1 (sr)
TW (1)	TWI291950B (sr)
UA (1)	UA78731C2 (sr)
WO (1)	WO2003044014A1 (sr)
ZA (1)	ZA200402945B (sr)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101684091A (zh) *	2001-11-14	2010-03-31	先灵公司	类大麻苷受体配体
US7358268B2 (en) *	2002-12-04	2008-04-15	Sanofi-Aventis Deutschland Gmbh	Imidazole derivatives as factor Xa inhibitors
US7429581B2 (en) *	2002-12-23	2008-09-30	Sanofi-Aventis Deutschland Gmbh	Pyrazole-derivatives as factor Xa inhibitors
ES2337254T3 (es)	2003-02-14	2010-04-22	Glaxo Group Limited	Derivados de carboxamida.
US7539725B2 (en) *	2003-04-03	2009-05-26	Zix Corporation	Auditor system
EP1479675A1 (en) *	2003-05-19	2004-11-24	Aventis Pharma Deutschland GmbH	Indazole-derivatives as factor Xa inhibitors
EP1479677A1 (en) *	2003-05-19	2004-11-24	Aventis Pharma Deutschland GmbH	New indole derivatives as factor xa inhibitors
EP1479680A1 (en) *	2003-05-19	2004-11-24	Aventis Pharma Deutschland GmbH	Azaindole derivatives as Factor Xa inhibitors
US7741341B2 (en)	2003-05-19	2010-06-22	Sanofi-Aventis Deutschland Gmbh	Benzimidazole-derivatives as factor Xa inhibitors
US7223780B2 (en) *	2003-05-19	2007-05-29	Sanofi-Aventis Deutschland Gmbh	Triazole-derivatives as blood clotting enzyme factor Xa inhibitors
US7317027B2 (en) *	2003-05-19	2008-01-08	Sanofi-Aventis Deutschland Gmbh	Azaindole-derivatives as factor Xa inhibitors
WO2004108671A1 (en) *	2003-06-06	2004-12-16	Suven Life Sciences Limited	Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
TWI372050B (en)	2003-07-03	2012-09-11	Astex Therapeutics Ltd	(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
EP1568698A1 (en)	2004-02-27	2005-08-31	Aventis Pharma Deutschland GmbH	Pyrrole-derivatives as factor Xa inhibitors
EP1571154A1 (en) *	2004-03-03	2005-09-07	Aventis Pharma Deutschland GmbH	Beta-aminoacid-derivatives as factor Xa inhibitors
CA2570363A1 (en)	2004-06-18	2005-12-29	Biolipox Ab	Indoles useful in the treatment of inflammation
US7868037B2 (en)	2004-07-14	2011-01-11	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
JP2008506702A (ja)	2004-07-14	2008-03-06	ピーティーシーセラピューティクス，インコーポレーテッド	Ｃ型肝炎を治療するための方法
US7781478B2 (en)	2004-07-14	2010-08-24	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7772271B2 (en)	2004-07-14	2010-08-10	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
NZ553329A (en)	2004-07-22	2010-09-30	Ptc Therapeutics Inc	Thienopyridines for treating hepatitis C
FR2874015B1 (fr) *	2004-08-05	2006-09-15	Sanofi Synthelabo	Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
EP1807082A4 (en)	2004-10-26	2010-12-01	Janssen Pharmaceutica Nv	INHIBITOR COMPOUNDS OF XA FACTORS
EP1828152B1 (en) *	2004-12-08	2008-08-20	Bristol-Myers Squibb Company	Heterocyclic compounds as inhibitors of factor viia
EP2395000A1 (en)	2004-12-30	2011-12-14	Astex Therapeutics Limited	Benzimidazole compounds that modulate the activity of CDK, GSK and aurora kinases
FR2880625B1 (fr) *	2005-01-07	2007-03-09	Sanofi Aventis Sa	Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
AU2005325497A1 (en)	2005-01-19	2006-07-27	Biolipox Ab	Indoles useful in the treatment of inflammation
EP2308839B1 (en)	2005-04-20	2017-03-01	Takeda Pharmaceutical Company Limited	Fused heterocyclic compounds
FR2888847B1 (fr) *	2005-07-22	2007-08-31	Sanofi Aventis Sa	Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique
US8399666B2 (en)	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en)	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en)	2005-11-04	2011-07-12	Amira Pharmaceuticals, Inc.	5-lipdxygenase-activating protein (FLAP) inhibitors
WO2007077435A1 (en)	2005-12-30	2007-07-12	Astex Therapeutics Limited	Pharmaceutical compounds
HRP20130058T1 (hr) *	2006-01-24	2013-02-28	Eli Lilly & Company	Indolsulfonamidni modulatori progesteronskih receptora
US7943622B2 (en)	2006-06-06	2011-05-17	Cornerstone Therapeutics, Inc.	Piperazines, pharmaceutical compositions and methods of use thereof
WO2008001115A2 (en)	2006-06-29	2008-01-03	Astex Therapeutics Limited	Pharmaceutical combinations of 1-cyclopropyl-3- [3- (5-m0rphoolin-4-ylmethyl-1h-benzoimidazol-2-yl) -lh-1-pyrazol- 4-yl] -urea
CA2682356C (en) *	2007-04-16	2016-06-14	Abbott Laboratories	7-substituted indole mcl-1 inhibitors
BRPI0812594A2 (pt) *	2007-08-10	2015-06-23	Lundbeck & Co As H	Composto ou sal ou hidrato do mesmo, composição farmacêutica, métodos para modulação da atividade de um receptor p2x7, para tratamento de uma condição responsiva á modulação do receptor p2x7 em um paciente, para inibição de morte de células gangliônicas retinais em um paciente, para determinação da presença ou ausência de receptor p2x7 em uma amostra, preparação farmacêutica acondicionada, e, uso de um composto ou sal ou hidrato do mesmo.
TW200920369A (en)	2007-10-26	2009-05-16	Amira Pharmaceuticals Inc	5-lipoxygenase activating protein (flap) inhibitor
NZ586651A (en) *	2007-12-07	2012-06-29	Abbott Gmbh & Co Kg	5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
EP2227463B1 (de) *	2007-12-27	2016-08-17	AbbVie Deutschland GmbH & Co KG	Substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
KR101247840B1 (ko)	2008-02-22	2013-03-26	에프. 호프만-라 로슈 아게	아밀로이드 베타 조절제
BRPI0912267A2 (pt)	2008-05-23	2015-10-13	Amira Pharmaceuticals Inc	sal farmaceuticamente aceitável, composição farmacêutica, artigo de fabricação, métodos para tratar asma, rinite alérgica, doença, lesões gástricas e dor, métodos para prevenir broncoconstrição e rinite alérgica, uso de um sal farmaceuticamente aceitável, e, processo para a preparação de um sal farmaceuticamente aceitável.
GB0813142D0 (en)	2008-07-17	2008-08-27	Glaxo Group Ltd	Novel compounds
GB0813144D0 (en)	2008-07-17	2008-08-27	Glaxo Group Ltd	Novel compounds
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
EP2448938B9 (en)	2009-06-29	2015-06-10	Incyte Corporation	Pyrimidinones as pi3k inhibitors
WO2011075643A1 (en)	2009-12-18	2011-06-23	Incyte Corporation	Substituted heteroaryl fused derivatives as pi3k inhibitors
US8486967B2 (en) *	2010-02-17	2013-07-16	Hoffmann-La Roche Inc.	Heteroaryl substituted piperidines
EP2558463A1 (en)	2010-04-14	2013-02-20	Incyte Corporation	Fused derivatives as i3 inhibitors
US9062055B2 (en)	2010-06-21	2015-06-23	Incyte Corporation	Fused pyrrole derivatives as PI3K inhibitors
TW201249844A (en)	2010-12-20	2012-12-16	Incyte Corp	N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
WO2012125629A1 (en)	2011-03-14	2012-09-20	Incyte Corporation	Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US9126948B2 (en)	2011-03-25	2015-09-08	Incyte Holdings Corporation	Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
FR2974576B1 (fr) *	2011-04-29	2013-07-19	Sanofi Aventis	Derives de n-[(1h-pyrazol-1-yl)aryl]-1h-indole ou 1h- indazole-3-carboxamide, leur preparation et leurs applications en therapeutique
KR102030609B1 (ko)	2011-09-02	2019-10-11	인사이트 홀딩스 코포레이션	Ｐｉ３ｋ 억제제로서 헤테로시클릴아민
EP2819671A4 (en) *	2012-02-29	2016-05-11	Baruch S Blumberg Inst	INHIBITORS OF HEPATITIS B VIRUS WITH COVALENT CLOSED CIRCULAR DNA PREPARATION AND ITS USE METHOD
AR090548A1 (es)	2012-04-02	2014-11-19	Incyte Corp	Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
US20140303121A1 (en)	2013-03-15	2014-10-09	Plexxikon Inc.	Heterocyclic compounds and uses thereof
JP6325078B2 (ja)	2013-03-15	2018-05-16	プレキシコンインコーポレーテッドＰｌｅｘｘｉｋｏｎＩｎｃ．	ヘテロ環式化合物およびその使用
CN105829293B (zh) *	2013-12-20	2018-11-09	中国人民解放军军事医学科学院毒物药物研究所	新型哌啶氨甲酰类化合物、制备方法及其用途
WO2015176625A1 (zh)	2014-05-22	2015-11-26	南京明德新药研发股份有限公司	作为凝血因子Xa抑制剂的酰肼类化合物
WO2015191677A1 (en)	2014-06-11	2015-12-17	Incyte Corporation	Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
MX2017002985A (es) *	2014-09-10	2017-11-17	Epizyme Inc	Inhibidores de smyd.
JP6903580B2 (ja)	2014-12-29	2021-07-14	ザユナイテッドステイツオブアメリカ，アズリプレゼンテッドバイザセクレタリー，デパートメントオブヘルスアンドヒューマンサービシーズ	乳酸脱水素酵素の小分子阻害剤及びその使用方法
DK3831833T3 (da)	2015-02-27	2022-11-14	Incyte Holdings Corp	Fremgangsmåder til fremstillingen af en pi3k-inhibitor
WO2016183063A1 (en)	2015-05-11	2016-11-17	Incyte Corporation	Crystalline forms of a pi3k inhibitor
US9732097B2 (en)	2015-05-11	2017-08-15	Incyte Corporation	Process for the synthesis of a phosphoinositide 3-kinase inhibitor
EP3313846B1 (en) *	2015-06-25	2020-05-06	Promega Corporation	Thienopyrrole compounds and uses thereof as inhibitors of oplophorus-derived luciferases
KR101725451B1 (ko) *	2016-05-25	2017-04-13	한국화학연구원	N-(피페리딘-4-일)-1h-인돌-2-카복스아마이드 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 유로텐신-ⅱ 수용체 활성 관련 질환의 예방 또는 치료용 약학적 조성물
JP6965341B2 (ja) *	2016-10-18	2021-11-10	シェブロン・オロナイト・テクノロジー・ビー．ブイ．	船舶用ディーゼル潤滑油組成物
EP3562823B1 (en)	2016-12-28	2023-02-08	Promega Corporation	Functionalized nanoluc inhibitors
BR112019018691A2 (pt) *	2017-03-10	2020-04-07	Rutgers, The State University Of New Jersey	derivados de indol como inibidores de bomba de efluxo
EP3694855A1 (en)	2017-10-13	2020-08-19	Plexxikon Inc.	Solid forms of a compound for modulating kinases
CN119258070A (zh)	2018-06-01	2025-01-07	因赛特公司	治疗pi3k相关病症的给药方案
US20240059688A1 (en) *	2020-12-22	2024-02-22	Luxembourg Institute Of Health (Lih)	Conolidine analogues as selective ackr3 modulators for the treatment of cancer
CN116332818B (zh) *	2021-12-22	2023-12-15	王喆明	四氢吡咯衍生物及其应用
CN116554144B (zh) *	2022-01-27	2025-12-19	司马健	一种sj系列芳基苯胺类化合物及其制备方法与医药用途
TW202345806A (zh)	2022-03-31	2023-12-01	美商艾伯維有限公司	噻唑并〔５，４－ｂ〕吡啶ｍａｌｔ－１抑制劑

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3317524A (en) *	1965-02-04	1967-05-02	American Home Prod	Substituted 1, 2, 3, 4-tetrahydro-pyrazino[1, 2-a]indoles
FR2260332A1 (en) *	1974-02-12	1975-09-05	Delalande Sa	1-Phenyl-2-aminocarbonyl-indoles - with respiratory analeptic, antiinflammatory analgesic, vasodilator, diuretic and anti-ulcer activity
US4675332A (en) *	1984-12-10	1987-06-23	Warner-Lambert Company	Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
IE68593B1 (en) *	1989-12-06	1996-06-26	Sanofi Sa	Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
US5506134A (en)	1990-10-22	1996-04-09	Corvas International, Inc.	Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5833982A (en)	1991-02-28	1998-11-10	Zymogenetics, Inc.	Modified factor VII
US5788965A (en)	1991-02-28	1998-08-04	Novo Nordisk A/S	Modified factor VII
TW229140B (sr)	1992-06-05	1994-09-01	Shell Internat Res Schappej B V
FR2703995B1 (fr) *	1993-04-16	1995-07-21	Sanofi Elf	5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
US5518231A (en)	1993-04-19	1996-05-21	Xerox Corporation	Self adjusting sheet gripping apparatus
AU707653B2 (en)	1994-04-26	1999-07-15	Selectide Corporation	Factor Xa inhibitors
CA2342471C (en) *	1995-06-06	2002-10-29	Judith L. Treadway	Heterocyclecarbonylmethyl amine intermediates
EP0782989A4 (en) *	1995-07-18	1999-04-21	Kyowa Hakko Kogyo Kk	INDOL DERIVATIVES
JPH0987282A (ja) *	1995-09-21	1997-03-31	Kyowa Hakko Kogyo Co Ltd	チアゾール誘導体
WO1997045119A1 (en) *	1996-05-24	1997-12-04	Novartis Ag	Use of substance p antagonists for treating social phobia
FR2763337B1 (fr) *	1997-05-13	1999-08-20	Sanofi Sa	Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant
GB9716657D0 (en) *	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
PT1042287E (pt) *	1997-12-24	2005-08-31	Aventis Pharma Gmbh	Derivados de indole como inibidores do factor xa
WO1999037304A1 (en)	1998-01-27	1999-07-29	Aventis Pharmaceuticals Products Inc.	SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
EP0987274A1 (en)	1998-09-15	2000-03-22	Hoechst Marion Roussel Deutschland GmbH	Factor VIIa Inhibitors
JP4241970B2 (ja) *	1998-10-30	2009-03-18	中外製薬株式会社	アミド結合を有するインドール誘導体、及びモノ又はジアザインドール誘導体
JP2001002642A (ja) *	1999-06-21	2001-01-09	Nippon Nohyaku Co Ltd	複素環ジカルボン酸ジアミド誘導体及び除草剤並びにその使用方法
WO2001007436A2 (en)	1999-07-28	2001-02-01	Aventis Pharmaceuticals Inc.	Substituted oxoazaheterocyclyl compounds
US6486211B1 (en) *	1999-10-22	2002-11-26	Smithkline Beecham Corporation	Indole compounds
AU2001250783A1 (en)	2000-02-29	2001-09-12	Cor Therapeutics, Inc.	Benzamides and related inhibitors of factor xa
US6436965B1 (en) *	2000-03-02	2002-08-20	Merck Frosst Canada & Co.	PDE IV inhibiting amides, compositions and methods of treatment
AU2001268711A1 (en)	2000-06-23	2002-01-08	Bristol-Myers Squibb Pharma Company	Heteroaryl-phenyl substituted factor xa inhibitors
DE10147672A1 (de) *	2001-09-27	2003-04-10	Bayer Ag	Substituierte 2,5-Diamidoindole und ihre Verwendung
CN101684091A (zh) *	2001-11-14	2010-03-31	先灵公司	类大麻苷受体配体
EP1479677A1 (en) *	2003-05-19	2004-11-24	Aventis Pharma Deutschland GmbH	New indole derivatives as factor xa inhibitors
FR2888847B1 (fr) *	2005-07-22	2007-08-31	Sanofi Aventis Sa	Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique
FR2911604B1 (fr) *	2007-01-19	2009-04-17	Sanofi Aventis Sa	Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique

2001
- 2001-11-22 EP EP01127809A patent/EP1314733A1/en not_active Withdrawn
2002
- 2002-08-11 UA UA20040604882A patent/UA78731C2/uk unknown
- 2002-11-08 HR HR20040453A patent/HRP20040453A2/xx not_active Application Discontinuation
- 2002-11-08 JP JP2003545651A patent/JP4664592B2/ja not_active Expired - Fee Related
- 2002-11-08 CA CA2467374A patent/CA2467374C/en not_active Expired - Fee Related
- 2002-11-08 RU RU2004118710/04A patent/RU2299881C2/ru not_active IP Right Cessation
- 2002-11-08 IL IL16210502A patent/IL162105A0/xx unknown
- 2002-11-08 NZ NZ533044A patent/NZ533044A/en not_active IP Right Cessation
- 2002-11-08 ME MEP-430/08A patent/MEP43008A/xx unknown
- 2002-11-08 MX MXPA04004797A patent/MXPA04004797A/es active IP Right Grant
- 2002-11-08 HU HU0402063A patent/HUP0402063A3/hu unknown
- 2002-11-08 WO PCT/EP2002/012500 patent/WO2003044014A1/en not_active Ceased
- 2002-11-08 CN CNB028232488A patent/CN1283638C/zh not_active Expired - Fee Related
- 2002-11-08 PL PL368949A patent/PL210986B1/pl unknown
- 2002-11-08 EP EP02787604.4A patent/EP1451185B1/en not_active Expired - Lifetime
- 2002-11-08 KR KR1020047007838A patent/KR100954508B1/ko not_active Expired - Fee Related
- 2002-11-08 BR BR0214396-8A patent/BR0214396A/pt active Search and Examination
- 2002-11-08 RS YUP-404/04A patent/RS40404A/sr unknown
- 2002-11-08 KR KR1020107003845A patent/KR101033798B1/ko not_active Expired - Fee Related
- 2002-11-08 OA OA1200400142A patent/OA12727A/en unknown
- 2002-11-08 AU AU2002351918A patent/AU2002351918B2/en not_active Ceased
- 2002-11-19 PE PE2002001105A patent/PE20030593A1/es not_active Application Discontinuation
- 2002-11-20 AR ARP020104452A patent/AR037656A1/es active IP Right Grant
- 2002-11-20 TW TW091133782A patent/TWI291950B/zh not_active IP Right Cessation
- 2002-11-21 US US10/301,397 patent/US6906084B2/en not_active Expired - Lifetime
- 2002-11-22 MY MYPI20024375A patent/MY131516A/en unknown
2004
- 2004-04-19 ZA ZA2004/02945A patent/ZA200402945B/en unknown
- 2004-04-22 MA MA27647A patent/MA27350A1/fr unknown
- 2004-05-20 EC EC2004005115A patent/ECSP045115A/es unknown
- 2004-05-20 IL IL162105A patent/IL162105A/en not_active IP Right Cessation
- 2004-05-20 CO CO04046947A patent/CO5580764A2/es active IP Right Grant
- 2004-05-21 TN TNP2004000091A patent/TNSN04091A1/en unknown
- 2004-06-21 NO NO20042592A patent/NO327466B1/no not_active IP Right Cessation
- 2004-08-26 US US10/926,909 patent/US20050043302A1/en not_active Abandoned
2008
- 2008-05-12 US US12/119,013 patent/US20090069565A1/en not_active Abandoned

Also Published As

Publication number	Publication date
UA78731C2 (en)	2007-04-25
KR20040073441A (ko)	2004-08-19
HUP0402063A2 (hu)	2005-02-28
KR101033798B1 (ko)	2011-05-13
US6906084B2 (en)	2005-06-14
CN1589270A (zh)	2005-03-02
EP1451185A1 (en)	2004-09-01
WO2003044014A8 (en)	2004-07-22
CN1283638C (zh)	2006-11-08
TW200408625A (en)	2004-06-01
ECSP045115A (es)	2004-07-23
MXPA04004797A (es)	2004-08-11
RU2004118710A (ru)	2005-03-27
PL210986B1 (pl)	2012-03-30
US20090069565A1 (en)	2009-03-12
HK1070352A1 (en)	2005-06-17
HRP20040453A2 (en)	2005-08-31
PE20030593A1 (es)	2003-08-21
TNSN04091A1 (en)	2006-06-01
JP2005514365A (ja)	2005-05-19
CA2467374A1 (en)	2003-05-30
TWI291950B (en)	2008-01-01
CA2467374C (en)	2012-11-27
KR100954508B1 (ko)	2010-04-27
IL162105A (en)	2012-05-31
AU2002351918B2 (en)	2008-04-03
NO20042592L (no)	2004-06-21
WO2003044014A1 (en)	2003-05-30
HUP0402063A3 (en)	2008-03-28
EP1314733A1 (en)	2003-05-28
BR0214396A (pt)	2004-09-14
CO5580764A2 (es)	2005-11-30
ZA200402945B (en)	2005-02-23
RU2299881C2 (ru)	2007-05-27
PL368949A1 (en)	2005-04-04
NZ533044A (en)	2005-11-25
AR037656A1 (es)	2004-12-01
US20050043302A1 (en)	2005-02-24
IL162105A0 (en)	2005-11-20
NO327466B1 (no)	2009-07-06
JP4664592B2 (ja)	2011-04-06
EP1451185B1 (en)	2014-08-06
MEP43008A (en)	2011-02-10
MA27350A1 (fr)	2005-06-01
US20030199689A1 (en)	2003-10-23
AU2002351918A1 (en)	2003-06-10
MY131516A (en)	2007-08-30
KR20100027248A (ko)	2010-03-10
RS40404A (sr)	2007-11-15

Publication	Publication Date	Title
CA2467374C (en)	2012-11-27	Indole-2-carboxamides as factor xa inhibitors
AU2004238495B2 (en)	2010-07-22	New indole derivatives as factor Xa inhibitors
US7910606B2 (en)	2011-03-22	Pyrazole-derivatives as factor Xa inhibitors
US20080280946A1 (en)	2008-11-13	Azaindole-Derivatives As Factor Xa Inhibitors
AU2004238500B2 (en)	2010-07-22	Azaindole-derivatives as factor Xa inhibitors
OA13168A (en)	2006-12-13	Benzimidazole-derivatives as factor Xa inhibitors.